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Abstract 
Where there is smoke, there is risk: Social and pharmacological exposure to 
smoking increase risk for smoking behavior during adolescence 
 
Simon Racicot, Ph.D. 
 
Concordia University, 2014 
 
Social exposure to smoking, or observing smokers, is a robust predictor of 
adolescent smoking. Recently, an emerging line of research posited that nicotine 
exposure from secondhand smoke could predict nicotine dependence symptoms and 
smoking initiation among never-smokers, given that nicotine is a psychoactive substance 
present in secondhand smoke. The objective of the present research program was to 
evaluate social exposure to smoking and pharmacological exposure to nicotine from SHS 
as differential predictors of smoking precursors, such as smoking expectancies, smoking 
susceptibility, or nicotine dependence symptoms. Adolescent never-smokers constitute an 
ideal population to study, provided that nicotine exposure from SHS is not confounded by 
active smoking in that population. This dissertation includes three original quantitative 
studies. 
Using longitudinal data from the NDIT study, Study 1 identified exposure to peer 
smoking as a significant predictor of nicotine dependence symptoms among never-
smokers, which provided convincing evidence that adolescents do not mistakenly endorse 
such symptoms. Using cross-sectional data from the AdoQuest Study, Study 2 developed 
the Social Smoking Situations (S3) Scale, an enhanced psychometric instrument 
measuring the situational contexts in which social exposure to smoking occurs. 
Compared with existing measures of social exposure (e.g., “who is smoking”), the S3 
Scale was a stronger predictor of smoking behavior and smoking expectancies. Finally, 
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Study 3 investigated the differential relations of social and pharmacological exposure to 
smoking with smoking precursors, using cross-sectional data from the AdoQuest study. 
This study is the first to demonstrate significant effects of pharmacological exposure to 
nicotine on smoking expectancies and nicotine dependence symptoms in a sample of 
adolescent never-smokers. 
Overall, this research program provided scientific evidence that exposure to 
nicotine is a risk factor for smoking among adolescent never-smokers. Its distinctive 
feature pertains to its emphasis on dismantling the major components of smoke exposure 
(social vs. pharmacological), and examining their relative consequences on increasing 
risk for adolescent smoking. It is recommended that future studies use longitudinal data 
to investigate the unique effects of social and pharmacological exposure on smoking 
initiation. Finally, current findings could be used to promote complete smoking bans in 
adolescents’ homes and cars. 
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GENERAL INTRODUCTION 
Prevalence of Smoking during Adolescence 
 
 Public health organizations around the world have labeled tobacco smoking as the 
most preventable source of disease, chronic disability, and death (U.S. Department of 
Health and Human Services [USDHHS], 2004; World Health Organization, 2013), and 
have reported that tobacco dependence is as powerful a dependency as that of illegal 
drugs, such as cocaine or heroin (USDHHS, 1988). In spite of multiple prevention efforts 
aiming to decrease the prevalence rates of smoking, the number of individuals who 
continue to smoke remains high, and children and adolescents are no exception to this 
trend. In fact, tobacco smoking typically begins during adolescence and continues well 
into adulthood (Chassin, Presson, Pitts, & Sherman, 2000). The most recent Canadian 
Youth Smoking Survey (2010-11 YSS; Health Canada, 2012) revealed that on average, 
youth smoke their first cigarette at age 13. Youth who smoke daily in grades 6-9 (1%) 
and grades 10-12 (5%) smoke approximately nine cigarettes per day. Further, this survey 
showed that 15.5% of Canadian youth in grades 6-9 and 40% in grades 10-12 have tried 
smoking. These rates were higher in the province of Québec where 24.4% of youth in 
grades 6-9 and 44% in grades 10-12 have ever tried smoking (Health Canada, 2012). 
Secondhand Smoke Exposure: Nature and Prevalence 
 Although research convincingly shows that active smoking is an unhealthy 
lifestyle behavior choice, passive smoking or exposure to secondhand smoke (SHS) 
represents another considerable health concern. SHS can be detected in ambient air when 
a tobacco product burns (i.e., sidestream smoke) and when a smoker exhales tobacco 
smoke (i.e., mainstream smoke). Importantly, it has been associated with increasing rates 
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of pediatric conditions, including respiratory illness and sudden infant death syndrome 
(USDHHS, 2006), and behavior problems, such as attention deficit and hyperactivity 
disorder (Kabir, Connolly, & Alpert, 2011). The influential 2006 report of the U.S. 
Surgeon General concluded unequivocally that there is no such thing as a risk-free level 
of SHS exposure (USDHHS, 2006). In fact, Health Canada (2011) reported that SHS is 
comprised of more than 4000 chemicals of which 70 are carcinogenic substances; 
nicotine, tar, carbon monoxide, benzene, hydrogen cyanide, and formaldehyde are some 
of its principal components. According to the latest Canadian Tobacco Use Monitoring 
Survey (CTUMS 2012; Health Canada, 2013), 3.3% of children aged 0-11 years and 
6.5% of adolescents aged 12-17 years were exposed to SHS at home; prevalence rates 
were twice as high in Québec (7.2% for ages 0-11; 12.2% for ages 12-17; Health Canada, 
2013). Other North American statistics showed that overall, 53% of children are exposed 
to SHS (Centers for Disease Control and Prevention [CDC], 2010).  
In addition to acknowledging that SHS exposure contributes to negative health 
outcomes, an emerging line of research has posited that SHS exposure could also lead to 
behavioral sequelae, given that greater SHS exposure is linked to greater nicotine 
exposure. Due to the psychotropic effects of nicotine, repeated exposure to nicotine from 
SHS is increasingly recognized as a plausible risk factor for smoking initiation during 
adolescence (Becklake Ghezzo, & Ernst, 2005; Okoli, Kelly, & Hahn, 2007). In fact, 
some researchers have suggested the possibility of a “physiological pathway” between 
nicotine exposure from SHS and prospective smoking behavior (Anthonisen & Murray, 
2005), although the presence and nature of such a pathway remains to be identified 
empirically.  
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Physiological Effects of Nicotine Administration 
 The current state of knowledge is clear: nicotine is indisputably the psychoactive 
substance responsible for tobacco dependence in humans (Henningfield & Heishman, 
1995; Stolerman & Jarvis, 1995) and sensitization in animals (Vezina, McGehee, & 
Green, 2007). After inhalation, nicotine rapidly reaches the brain within about 10 seconds 
(Benowitz, 1988), and acts as an agonist on the nicotinic cholinergic receptors (nAChRs). 
Acetylcholine is the neurotransmitter that naturally binds to nAChRs (Benowitz, 2008; 
Wonnacott, Sidhpura, & Balfour, 2005) that comprise α-subtypes (α2-α10) and β-
subtypes (β2-β4; Dani & De Biasi, 2001; Mineur & Piciotto, 2008). Receptors with the 
α4β2 subtype are the most prevalent high-affinity binding sites for nicotine (Flores, 
Rogers, Pabreza, Wolfe, & Kellar, 1992). Tobacco use has been associated with the 
upregulation of nAChRs (Buisson & Bertrand, 2001; Littleton, 2001), which signifies 
there is a significant increase in the number of receptors on the cells. Upon nicotine 
binding in the ventral tegmental area of the brain, dopamine is released in the nucleus 
accumbens (Benowitz, 2010; Nestler, 2005). Dopamine is a neurotransmitter that is 
highly implicated in reward-seeking behaviors (Balfour, Wright, Benwell, & Birrell, 
2000; Benowitz, 2008; Di Chiara, 2000). The specific pathway between nicotine binding 
in the ventral tegmental area and dopamine release in the nucleus accumbens has been 
associated with nicotine dependence (ND) (Laviolette & van der Kooy, 2004). 
The effects of nicotine use on human neuroanatomy have been previously 
investigated, using autopsied brains. Compared to nonsmokers, smokers have greater 
density of nAChRs binding in different areas of the brain, including the hippocampal 
formation and neocortex, cerebellar cortex, gyrus rectus, and median raphe nuclei 
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(Benwell, Balfour, & Anderson, 1988), as well as the prefrontal and temporal cortices 
(Perry, Davila-Garcia, Stockmeier, & Kellar, 1999). The adolescent brain has been shown 
to be particularly vulnerable to the effects of nicotine (Slotkin, 2002), as nicotine 
interferes with normal neuronal activity in different brain regions, including the cortex 
and midbrain (Slotkin, Pinkerton, & Seidler, 2006). Nicotine exposure in adolescent 
animals has been associated with upregulation of nAChRs for more than a month after 
the last dose of nicotine (Abreu-Villaça et al., 2003; Trauth, Seidler, McCook, & Slotkin, 
1999). Moreover, adolescents appear to be more sensitive to the reinforcing effects of 
nicotine and less sensitive to its aversive effects (Torres, Tejeda, Natividad, & O’Dell, 
2008; Shram, Funk, Li, & Le, 2006). Taken together, research demonstrates that nicotine 
is a psychoactive substance associated with direct changes in the central nervous system. 
However, the question remains whether nicotine exposure from SHS is similarly capable 
of changing the brain, and whether such changes have an influence on smoking behavior. 
Further research is warranted to address these questions, especially in adolescent 
populations. 
Measurement of Nicotine Exposure from SHS 
 In their seminal review article, Jaakkola and Jaakkola (1997) indicated that 
nicotine exposure through SHS can be measured with biomarkers or passive nicotine 
monitors. Other methods, such as questionnaires, interviews, or monitors measuring 
inhalable suspended particles are unable to provide estimates specific to nicotine. Okoli, 
Kelly, and Hahn (2007) reported in their review article that biomarkers can be collected 
from blood, saliva, urine, hair, or nails, and are affected by bodily processes like 
metabolism and elimination (U.S. Environmental Protection Agency, 1992). Thus, 
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biomarkers are a valid measure of one’s pharmacological dose of nicotine. Specifically, 
nicotine biomarkers of SHS exposure measure either the amount of nicotine or its 
principal metabolite, cotinine. After nicotine intake, more than 80% of nicotine is 
converted into cotinine by the hepatic enzyme CYP2A6 (Benowitz, 1996). Jaakkola and 
Jaakkola (1997) indicated that the half-life of cotinine ranges from 32-82 hours in 
children, reflecting a window of exposure of 2-4 days. Relatedly, the passive nicotine 
monitor allows for an estimation of the total concentration of nicotine to which 
individuals are exposed in their environment (Hammond & Leaderer, 1987; Leaderer & 
Hammond, 1991). The monitor can be worn on oneself or left in a particular place to 
capture the total concentration of airborne nicotine. Unlike the biomarkers of SHS 
exposure, the passive nicotine monitor is unaffected by bodily functioning. Taken 
together, it appears that nicotine exposure is best measured by a combination of 
biomarkers and passive nicotine monitors, which permits measurement by triangulation. 
Nonsmokers and Nicotine Exposure from SHS  
 Epidemiological data have revealed that nicotine exposure among nonsmokers 
can yield biological concentrations of nicotine comparable to those found in smokers. 
When examining nonsmoking employees exposed to SHS at work, researchers have 
found that the amount of nicotine in their hair was slightly lower than that of smokers 
(6.69 vs. 7.92 ng/mg: Al-Delaimy, Fraser, & Woodward, 2001; 1.03 vs 1.19 ng/mg: 
Dimich-Ward, Gee, Brauer, & Leung, 1997). Moreover, experimental data indicate that 
when exposed to the same concentration of airborne nicotine, nonsmoking children 
displayed higher biological doses of nicotine than nonsmoking adults, after adjusting for 
weight (2.3 mg/kg vs. 1.7mg/kg; Willers, Skarping, Dalene, & Skerfving, 1995). Nicotine 
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doses were also higher in children (27%) than adults (16%) seven days after the 
exposure, due to a smaller lung volume. Thus, nonsmoking youth appear to be more 
vulnerable to nicotine exposure than nonsmoking adults. Using blood samples, Pacifici 
and colleagues (1995) reported blood concentrations of nicotine in nonsmokers that, 
interestingly, were shown to have psychoactive effects in smokers (discriminative cue: 
Perkins, Fonte, Sanders, Meeker, & Wilson, 2001). Taken together, these studies 
convincingly demonstrate that never-smokers exposed to nicotine from SHS are not 
nicotine-naïve, as they are pharmacologically exposed to nicotine present in SHS.  
SHS Exposure as a Risk Factor for Smoking Behavior 
 Within the past decade, researchers have begun to consider that nicotine exposure 
from SHS exposure in itself may be a risk factor for smoking behavior. Relying on an 
objective measure of pharmacological smoke exposure in nonsmoking children, Becklake 
et al. (2005) reported that salivary cotinine predicted smoking initiation four years later, 
even after adjusting for the number of smokers at home, which is considered a well-
established social predictor of smoking initiation. This longitudinal study was the first to 
reveal the plausibility of behavioral sequelae related to nicotine exposure from SHS. 
Next, Okoli, Rayens, and Hahn (2007) also used an objective measure of 
pharmacological smoke exposure and demonstrated that nonsmoking adults with higher 
hair nicotine values were more likely to endorse ND symptoms. Thereafter, Bélanger and 
colleagues (2008) found that a small proportion of never-smoking children endorsing 
SHS exposure inside an automotive vehicle (4.6%) endorsed ND symptoms, even after 
ruling out the influence of sibling and peer smoking. Although these researchers did not 
measure SHS exposure objectively, their intriguing findings sparked curiosity regarding a 
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plausible link between nicotine exposure and ND symptoms among never-smokers.  
Of growing importance is the possibility that endorsing ND prior to smoking 
initiation represents a risk factor for eventual smoking behavior. Using longitudinal data 
from the Nicotine Dependence in Teens (NDIT) study, O’Loughlin, Karp, Koulis, 
Paradis, and DiFranza (2009) found that endorsing ND symptoms predicted first puff 
smoking and onset of daily smoking. Subsequently, Racicot, McGrath, and O’Loughlin 
(2011a) measured the differential effects of pharmacological smoke exposure and social 
exposure to smoking on smoking precursors among never-smoking adolescents, using 
cross-sectional data. To methodologically tease apart pharmacological smoke exposure 
from social exposure to smoking, Racicot and colleagues (2011a) used both salivary 
cotinine and self-report questions (i.e., number of smokers, number of contextual 
situations of smoke exposure). Number of smokers among parents, siblings, and peers 
independently predicted key smoking precursors, namely, ND symptoms, smoking 
susceptibility, and expected benefits of smoking; however, salivary cotinine did not 
predict any precursors, most likely due to the low prevalence of SHS exposure observed 
in their sample. This latter study was the first step in trying to document a relation 
between nicotine exposure from SHS and smoking precursors, given that influential 
sources of social exposure to smoking had been controlled for statistically. The authors 
recommended that their findings be replicated and extended using different types of 
biomarkers and using a wider range of smoking precursors. Altogether, these studies 
provided preliminary yet credible support to the hypothesis that pharmacological 
exposure to nicotine represents a unique risk factor for smoking initiation and progression 
during adolescence. However, the number of studies remains scarce and further research 
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endeavors are warranted. 
Smoking Milestones and Early Reports of ND Symptoms 
The natural course of the development of smoking behavior and ND during 
adolescence has been examined. In contrast to the widely held assumption that ND 
develops from daily use over a long period of time, prospective cohort-based studies have 
shown that ND symptoms can emerge soon after initiation. The NDIT study revealed that 
after smoking their first puff of cigarette (0 months), adolescents reported having 
cravings (4.5 months), feeling physically addicted to cigarettes (5.4 months), and having 
withdrawal symptoms (11.0 months), two years prior to meeting ICD-10 criteria for ND 
dependence (40.6 months; Gervais, O’Loughlin, Meshefedjian, Bancej, & Tremblay, 
2006). In the Development and Assessment of Nicotine Dependence in Youth (DANDY) 
study, DiFranza et al. (2007) observed that ND symptoms could develop as soon as only 
two days after inhaling smoke from a first cigarette. Further, DiFranza and colleagues 
(2007) found that adolescents who felt relaxed when inhaling smoke from their first 
cigarette were more likely to report ND symptoms. Scragg, Wellman, Laugesen, and 
DiFranza (2008) later reported that 25% of adolescents who endorsed ND symptoms had 
smoked only one cigarette in their lifetime. Taken together, these findings provide 
interesting evidence supporting the idea that ND may develop rapidly after the onset of 
active smoking during adolescence. Considering that: 1) nonsmokers exposed to SHS can 
absorb quantities of nicotine similar to those observed in smokers (Al-Delaimy et al., 
2001; Dimich-Ward et al., 1997); 2) such quantities in nonsmokers have been linked to 
psychoactive effects in smokers (Pacifici et al., 1995; Perkins et al., 2001); and 3) 
adolescent smokers can progress rapidly to ND soon after active smoking is initiated 
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(Gervais et al., 2006; DiFranza et al., 2007), the question remains whether nicotine 
exposure from SHS among never-smokers leads to neuroadaptations that would, in turn, 
confer greater risk for smoking initiation during adolescence. 
Social Exposure to Smoking as a Risk Factor for Smoking Behavior 
 One of the most well-established, robust mechanisms for smoking behavior, 
especially initiation, is social exposure to smoking in one’s environment (e.g., social 
learning; USDHHS, 2012). During adolescence, smoking by parents, siblings, and friends 
represent the main sources of social exposure to smoking (Avenevoli & Merikangas, 
2003; Hoffman, Sussman, Unger, & Valente, 2006). According to the Social Learning 
Theory (Bandura, 1977), adolescents observe and imitate the behavior of smokers whom 
they consider role models. Traditionally, social learning theorists posited that adolescents 
whose role models include parents, siblings, or peers who smoke are more likely to take 
up smoking than those whose role models do not smoke. However, such theorists omitted 
to recognize that observing smokers does not confer only greater social influence, but 
also greater pharmacological exposure to SHS and its components, such as nicotine 
(Okoli, Kelly, & Hahn, 2007; Racicot et al., 2011a). Consequently, further research needs 
to examine the potential effects of pharmacological exposure to nicotine from SHS on 
adolescent smoking.   
Objectives of the Present Research Program 
To convincingly contend that pharmacological exposure to nicotine has the 
potential to predict smoking behavior uniquely, researchers ought to use biomarkers 
and/or passive nicotine monitors while statistically controlling for social exposure to 
smoking. Previously reported studies (Becklake et al., 2005; Okoli, Rayens, & Hahn, 
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2007) provide compelling, preliminary evidence that pharmacological exposure to 
nicotine may confer greater risk for smoking behavior due to the psychoactive effects of 
nicotine. Thus, it could be plausible that both pharmacological exposure to SHS and 
social exposure to smoking contribute to smoking initiation among adolescents via their 
differential effects on smoking precursors. 
Adolescent never-smokers constitute an ideal population to study when 
considering pharmacological exposure to nicotine through SHS as a risk factor for 
smoking initiation. First, estimates of nicotine exposure are not biased by active smoking, 
given that they reflect nicotine exposure through passive smoking exclusively. Second, 
investigating risk for smoking initiation enables researchers to identify which adolescent 
never-smokers are more likely to initiate smoking and which adolescent never-smokers 
are less likely to initiate. Importantly, there is a consistent literature which agrees upon 
variables that are precursors to smoking during adolescence. Examples of such precursors 
include distinct theoretical concepts, such as smoking expectancies (Hine, Summers, 
Tilleczek, & Lewko, 1997), smoking susceptibility (Pierce, Choi, Gilpin, Parkas, & 
Merritt, 1996), and ND symptoms (Bélanger et al., 2008; O’Loughlin et al., 2009). Third, 
researchers can evaluate whether pharmacological exposure and social exposure to 
smoking differentially affect the precursors.  
 Study 1 Aim.  The literature pertaining to ND symptoms has reported the 
unexpected finding that never-smoking adolescents self-report ND symptoms (e.g., 
“feeling mentally addicted to cigarettes”, “feeling like one really needs a cigarette”); this 
finding has been found across independent samples (e.g., Bélanger et al., 2008; DiFranza 
et al., 2000; Okoli, Richardson, Ratner, & Johnson, 2009; Prokhorov, Hudmon, 
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Cinciripini, Marani, 2005; Racicot et al., 2011a). Importantly, endorsing ND symptoms 
has been associated prospectively with smoking a first puff of cigarette and daily 
smoking (O’Loughlin et al., 2009), indicating that ND is a risk factor for smoking 
behavior during adolescence. However, there is a dearth of research investigating the 
reasons why adolescents who have never smoked any cigarettes endorse items pertaining 
to ND. Specifically, this scientific discovery is highly incompatible with current 
conceptualization of ND, which postulates that nicotine use must occur daily (APA, 
2000). Exposure to smoking has been hypothesized as one of the mechanisms by which 
never-smoking adolescents develop ND symptoms. To bridge gaps in scientific research, 
the aim of Study 1 was to identify potential predictors of ND symptoms in a sample of 
never-smoking adolescents, using longitudinal data. 
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ABSTRACT 
Background: Recent cross-sectional studies suggest some adolescents who have never 
smoked cigarettes experience nicotine dependence (ND) symptoms and that exposure to 
second-hand smoke, social exposure to smoking, and alcohol use are plausible correlates. 
The aim of this study was to replicate and extend these findings by investigating possible 
predictors of ND symptoms longitudinally. 
Method: Participants included 847 secondary school students who had never smoked 
cigarettes enrolled in the Nicotine Dependence in Teens Study.  Adolescents completed 
self-report questionnaires measuring smoking status, ND symptoms, and risk factors for 
ND in smokers (i.e., socio-demographic indicators, social exposure to smoking, 
psychosocial indicators, and substance use) in 20 survey cycles from 7-11th grade.  
Generalized estimating equations, which account for repeated measures within 
individuals, were used to test the predictors of ND symptoms. 
Results:  Consistent with previous research, 7.88% of never-smokers across all cycles 
endorsed at least one ND symptom.  Younger age (p≤.001), country of birth (p≤.05), peer 
smoking (p≤.001), teacher smoking (p≤.05), depression (p≤.05), stress (p≤.001), lower 
self-esteem (p≤.05), impulsivity (p≤.05), and alcohol use (p≤.001) predicted greater ND 
symptoms in multivariable modeling. 
Conclusions: Replicating previous cross-sectional findings, peer smoking and alcohol 
use predicted ND symptoms among never-smoking adolescents.  Extending these 
findings, previous predictors only observed among ever-smokers, including socio-
demographic and psychosocial indicators, also predicted ND symptoms.  This 
longitudinal investigation demonstrated the temporal relation of the predictors preceding 
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ND symptoms.  Future research should consider longer prospective studies with younger 
children to capture early onset of ND symptoms and with longer follow-up to detect 
eventual smoking uptake. 
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1. Introduction 
Nicotine dependence (ND) is defined by symptoms of withdrawal, tolerance, and 
difficulty controlling tobacco use during a 12-month period (American Psychiatric 
Association & American Psychiatric Association Task Force on DSM-IV [APA], 2000).  
According to this clinical conceptualization, daily smoking is a requisite criterion for its 
diagnosis. However, this notion has been challenged by research suggesting that ND can 
be reported not only soon after smoking initiation, but also before initiation. The aim of 
the present study was to identify predictors of ND symptoms in a longitudinal sample of 
adolescent never-smokers. 
Early reports of ND symptoms have been observed among ever-smokers.  
DiFranza et al. (2000) found that 22% of adolescents experienced ND symptoms within 
the first month following consumption of at least one cigarette, with 6% reporting at least 
one symptom in the first two weeks. Surprisingly, a small percentage of never-smokers 
endorsed “really needing a cigarette” (2.5%) and “having strong cravings to smoke” 
(1.7%).  Following smoking initiation (0 mos), 20% of adolescent smokers reported 
mental addiction (2.5 mos), cravings (4.5 mos), physical addiction (5.4 mos), withdrawal 
symptoms (11.0 mos) and tolerance (13.0 mos), well before the onset of weekly smoking 
(19.4 mos) and the development of ICD-10 dependence (40.6 mos; Gervais, O'Loughlin, 
Meshefedjian, Bancej, & Tremblay, 2006). Such findings provide convincing evidence 
that ND symptoms can be reported early in the course of smoking. Subsequent research 
examined risk factors during adolescence associated with early reports of ND among 
smokers. 
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1.1. Predictors of ND Symptoms during Adolescence in Smoking Populations  
Social exposure to smoking by significant others during adolescence is associated 
not only with smoking behavior (O'Loughlin, Karp, Koulis, Paradis, & Difranza, 2009), 
but also with ND.  Parental smoking (Brook, Saar, Zhang, & Brook, 2009; Kleinjan et al., 
2012) and parental ND (Hu, Griesler, Schaffran, & Kandel, 2011) during adolescence 
were found to predict ND in adolescent and adult smokers.  Further, sibling smoking and 
peer smoking predicted ND in adolescent smokers (Audrain-McGovern et al., 2007; de 
Leeuw, Engels, Vermulst, & Scholte, 2009; Hu et al., 2011; Wileyto et al., 2009). 
Psychosocial indicators have also been identified as risk factors for ND among 
smoking adolescents.  Depressed mood and novelty-seeking predicted ICD-10 ND and 
loss of autonomy over tobacco use (DiFranza et al., 2007; Karp, O'Loughlin, Hanley, 
Tyndale, & Paradis, 2006).  Moreover, externalizing behavior problems (Hu et al., 2011; 
Storr, 2008) have been identified as risk factors, whereas impulsiveness was inversely 
associated with ICD-10 ND (DiFranza et al., 2007). With respect to substance use, 
alcohol has been found to predict ND among smoking adolescents (Storr, 2008; Wileyto 
et al., 2009).  
In addition to identifying risk factors for ND, growth-modeling studies 
demonstrate that ND emerges through longitudinal trajectories during adolescence (Hu, 
Muthen, Schaffran, Griesler, & Kandel, 2008; Kleinjan et al., 2010; Kleinjan et al., 
2012).  Trajectories are based on distinct profiles (e.g., severity, timing, symptoms).  
Factors predicting trajectory membership include conduct disorder, parental ND, novelty-
seeking (Hu et al., 2008), parental and peer smoking, and depression (Kleinjan et al., 
2010).  Taken together, social exposure to smoking, psychosocial risk factors, and 
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substance use have been found to predict ND and trajectory membership in adolescent 
smokers. 
1.2. ND Symptoms during Adolescence in Tobacco-Naïve Populations 
Extant literature demonstrates ND symptoms can be reported not only by 
smokers, but also by never-smokers.  It is plausible that second-hand smoke exposure 
(SHS) explains this unexpected and intriguing observation.  Prokhorov, Hudmon, 
Cinciripini, and Marani (2005) found that the prevalence of 5 of 7 withdrawal symptoms 
was similar in never- and former smokers. Bélanger et al. (2008) reported 4.6% of never-
smoking 5th graders endorsed at least one ND symptom, and SHS exposure in cars 
(Hedges g=.09), sibling smoking (g=.14), and peer smoking (g=.10) were associated with 
ND symptoms; parental smoking was not associated (g=.06).  Racicot, McGrath, and 
O’Loughlin (2011a) found that the number of smokers among parents, siblings, and peers 
(g=.16) predicted ND symptoms in adolescent never-smokers.  Moreover, Racicot, 
McGrath, and O’Loughlin (2011b) found 6.2% of never-smokers endorsed at least one 
ND symptom at baseline.  Alcohol use (g=.11) and peer smoking (g=.07) were associated 
with ND symptoms; parental (g=.02) and sibling smoking (g=.02) were not associated.  
Relatedly, never-smoking adolescents reporting ND symptoms have an increased 
likelihood of smoking susceptibility (Okoli, Richardson, Ratner, & Johnson, 2009) and 
smoking initiation (O'Loughlin et al., 2009).  Taken together, there is emerging evidence 
that never-smokers endorse ND symptoms, that smoke exposure itself predicts which 
never-smokers will endorse these symptoms, and that ND symptoms are a risk factor for 
eventual initiation. 
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 To date, cross-sectional data indicate ND has been observed in never-smoking 
populations, and social exposure to smoking and substance use are correlates of ND 
symptoms.  Given that ND predicts smoking susceptibility and initiation, identifying 
predictors of ND symptoms among never-smokers warrants further investigation.  The 
current objective was to identify predictors of ND symptoms in a school-based, 
longitudinal sample of adolescents who had never smoked.  Potential predictors were 
selected based on previously demonstrated associations with ND in adolescent smokers 
and included socio-demographic indicators, social exposure to smoking, psychosocial 
indicators, and substance use.   
2. Method 
2.1. Procedure and Participants 
Nicotine Dependence in Teens (NDIT) is a longitudinal cohort of 1293 7th grade 
students, aged 12-13 years at baseline, designed to investigate the onset and development 
of cigarette smoking and ND.  Students were recruited in a convenience sample of 10 
public schools in Montréal (Québec, Canada) selected in partnership with school boards 
and principals.  To maximize representativeness, schools were purposely selected from 
urban, suburban, and rural settings, as well as low, moderate, and high socioeconomic 
districts.  Data were collected in 20 survey cycles from 1999 to 2005 (4 per school year 
from grade 7 to 11).  Self-report questionnaires were administered at school in the 
language of instruction (i.e., English or French).  All participants provided assent; 
informed parental consent was obtained in signed consent forms.  NDIT received ethics 
approval from the Centre de recherche du CHUM (#ND06.087). 
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2.2. Measures 
2.2.1. Smoking Status. Smoking status was assessed at each survey cycle using two items: 
“Have you ever in your life smoked a cigarette, even just a few puffs?” (No to Yes, more 
than 10 times) and “Check the one box that describes you best…” (I have never smoked a 
cigarette, even just a few puffs to I smoke cigarettes every day).  Never-smoking was 
defined conservatively as having never smoked a cigarette, not even a few puffs.  
2.2.2. ND Symptoms. ND symptoms were assessed with items adapted from an 
ND/craving symptom indicator (O'Loughlin, DiFranza, et al., 2002).  Adolescents rated 
four items on a 4-point scale: “When you see other kids your age smoking cigarettes, how 
easy is it for you not to smoke?” (Very easy to Very difficult); “How often have you felt 
like you really need a cigarette?” (Never to Often); “How physically addicted to smoking 
cigarettes are you?” (Not at all to Very); and “How mentally addicted to smoking 
cigarettes are you?” (Not at all to Very).  The original ND/craving symptom indicator 
was based on a sample of smoking adolescents and evidenced excellent internal 
reliability (Cronbach’s α=.94), test-retest reliability (ICC=.91), and convergent validity 
with the Hooked on Nicotine Checklist (r=.91) and ICD-10 (r=.82).  The adapted items 
were those four answered by never-smokers; principal components analysis revealed the 
original component structure was retained (i.e., all items loaded on one component; all 
loadings >.6).  Consistent with previous scoring schemes (Bélanger et al., 2008; Racicot 
et al., 2011b), items were summed to yield a composite score (range 0-12).  Prevalence 
data are estimated for those who endorse at least one ND symptom (i.e., non-zero score). 
2.2.3. Socio-demographics. Socio-demographic data included age, sex, language spoken 
at home, country of birth, parental education, and perceived family income. 
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2.2.4. Social Exposure to Smoking 
2.2.4.1. Adult Smoking. Adolescents indicated whether adults residing in their household 
smoked cigarettes, based on a list of 10 family members (e.g., mother, father, aunt). The 
response categories were summed to yield the total number of smoking adults (range 0-
10). 
2.2.4.2. Sibling Smoking. Adolescents reported how many siblings, including step- or 
half-siblings, smoked.  The response categories were summed to yield the total number of 
smoking siblings. 
2.2.4.3. Peer Smoking. Adolescents answered, “How many of the friends whom you 
usually hang out with smoke cigarettes?” using a 5-point scale (None to Most or all). 
2.2.4.4. Schoolmate and School Personnel Smoking. Adolescents answered, “I see 
students smoke near the school” using a 3-point scale (Not at all true to Very true). A 
second question was asked about teachers/school staff. 
2.2.5. Psychosocial Indicators 
2.2.5.1. Depression. Depression was measured with the six-item Mellinger Depressive 
Symptoms Scale (Kandel & Davies, 1982).  Adolescents rated items over the past 3 
months using a 4-point scale (Never to Often).  Items are summed to create a total score 
(range 0-18); higher scores indicate greater depression.  This measure evidences good 
internal consistency (α=.89, Chaiton, Cohen, O'Loughlin, & Rehm, 2010; α=.85, present 
study). 
2.2.5.2. Stress. Stress was measured using a list of stressful life events typically 
encountered during adolescence (e.g., breaking up with girlfriend, parental divorce; 
Deschenes, 1997).  Adolescents rated whether they were worried or stressed about 15 
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items over the past 3 months on a 4-point scale (Not at all to A whole lot).  Items are 
summed to create a total score (range 0-45); higher scores indicate greater stress.  This 
scale has good internal consistency (α=.83-.89, Deschenes, 1997; α=.79, present study). 
2.2.5.3. Perceived Academic Performance. Adolescents rated their academic performance 
in response to the question, “I’m not doing well at school” on a 3-point scale (Not at all 
true to Very true).   
2.2.5.4. Self-Esteem. Self-esteem was measured using Rosenberg’s Self-Esteem Scale 
(1965; Vallières & Vallerand, 1990). Adolescents rated nine items over the past 3 months 
on a 3-point scale (Not at all true to Very true).  Items are summed to create a total score 
(range 0-18); higher scores indicate higher self-esteem.  This scale displays good test-
retest reliability (r=.84) and internal consistency (α=.88, Vallières & Vallerand, 1990; 
α=.80, present study). 
2.2.5.5. Novelty-Seeking. Novelty-seeking was assessed using nine items based on 
Cloninger’s Tridimensional Personality Questionnaire (e.g., “When nothing new is 
happening, I usually start looking for something that is exciting”; Cloninger, 1987) rated 
on a 5-point scale (Not at all true to Very true).  Items are summed to yield a total score 
(range 0-36); higher scores indicate greater novelty-seeking.  This scale has good internal 
consistency (α=.77, Wills, Windle, & Cleary, 1998; α=.81, present study).  
2.2.5.6. Impulsivity. Impulsivity was assessed with an abbreviated version of the Eysenck 
Impulsivity Scale (Eysenck & Eysenck, 1977), which has been previously validated with 
adolescents (Wills et al., 1998).  Adolescents rated seven items on a 5-point scale (Not at 
all true to Very true).  Items are summed to yield a total score (range 0-28); higher scores 
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indicate greater impulsivity.  This measure evidences good internal consistency (α=.87, 
Wills et al., 1998; α=.87, present study). 
2.2.6. Substance Use.  Frequency of other tobacco products and alcohol use in the past 
three months was assessed separately with two items (“smoke cigar or cigarillo”, “drink 
beer, wine or hard liquor”) using a 5-point scale (Never to Usually every day). 
2.3. Data Analysis 
The initial sample was comprised of never-smokers at cycle 1.  At each 
subsequent survey cycle, smoking status was ascertained to verify whether participants 
still met the never-smoking inclusion criterion.  Participants were excluded at the given 
cycle that they reported ever-smoking and every cycle thereafter.  For example, a 
participant reporting smoking for the first time at cycle 5 would be included from cycles 
1-4, but excluded from cycles 5-20.  Participants whose smoking status was unknown at 
any follow-up cycle were similarly excluded.  This conservative criterion was used to 
ensure the sample was exclusively never-smokers. 
Given the design of NDIT, some questions were asked at every cycle, while 
others were measured less frequently (detailed study design provided in O'Loughlin et al., 
2009). Missing values on questions that were asked once or 2-3 times were substituted in 
two steps. First, for questions measured only once, the same value was imputed for all 
cycles.  For variables measured 2-3 times, the value from the last available observation 
was carried backwards.  Second, multiple imputation was used for all the remaining 
missing observations, which included missing values on questions asked at each cycle, 
questions asked once or 2-3 times, and cycles that had been skipped.  Missing values 
were imputed 20 times in Amelia II (Honaker, King, & Blackwell, 2012). 
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Generalized estimating equations (GEE), with the independent correlation 
structure, were employed to account for repeated measures within participants. Given that 
ND symptoms were coded as a continuous score, analyses were conducted with linear 
regression modeling. Using an analytic strategy similar to that in earlier NDIT analyses 
(O'Loughlin et al., 2009), potential predictors at each cycle were used to predict ND 
symptoms at the subsequent cycle (i.e., T1 variables to predict ND at T2, etc.).  This 
approach was utilized so predictors closest in time (3-4 months prior) would predict ND 
symptoms.  Data for all participants and cycles were pooled, in accordance with the 
pooling of repeated observations method (e.g., Cupples, D'Agostino, Anderson, & 
Kannel, 1988; D'Agostino et al., 1990; Karp, Abrahamowicz, Bartlett, & Pilote, 2004). 
Univariate and multivariable regression analyses were conducted separately for 
each potential predictor to evaluate its association with ND symptoms at the next cycle.  
All multivariable analyses were age- and sex-adjusted; additional covariates were 
included in the model if the correlation coefficient between the covariate and the 
potential predictor was ≥.20 (Hosmer & Lemeshow, 2000). Unstandardized beta 
coefficients, which are less affected by arbitrary features of the study design and 
population (Greenland, Schlesselman, & Criqui, 1986), were derived with their estimates 
of standard error and the corresponding Wald χ2 test statistic. 
3. Results 
3.1. Descriptive Statistics 
Among the entire NDIT cohort, adolescents participated in 16.3 survey cycles 
(SD=5.91).  Of these, 847 participants were never-smokers at baseline (Table 1).  
Compared to ever-smokers (n=446; Mage=12.99 yrs, SD=.73), never-smokers were 
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younger, t=9.59, p<.001, more likely to be born outside Canada, χ2=6.76, p<.01, 
attended an English-language school, χ2=75.88, p<.001, and spoke English at home, 
χ2=104.34, p<.001.  There were no sex differences, χ2=3.04, p=.08.  A total of 405 
participants reported ever smoking and were excluded at that corresponding cycle.  The 
prevalence of reporting at least one ND symptom among never-smokers, across all 
cycles, was 7.88% (SD=1.98; range 4.8-13.0%).  The attrition rate did not differ between 
never-smokers and ever-smokers, 25% over 20 cycles; t=1.13, p=.81. 
3.2. Predictors of ND Symptoms 
 Univariate and multivariable regression models are presented in Table 2.  In 
multivariable modeling, among the socio-demographic variables, younger age and being 
born in Canada were associated with greater ND symptoms, while controlling for 
covariates.  Other socio-demographic variables including sex, language spoken at home, 
family income, and parental education were not associated in the multivariable models.  
Among the social smoke exposure indicators, observing peer and teacher smoking were 
associated with greater ND symptoms, after controlling for covariates.  Living with adult 
smokers, having siblings who smoke, and being exposed to schoolmate smoking were not 
associated in the multivariable models.  Among the psychosocial indicators, higher self-
reported depression, stress, and impulsivity, as well as lower self-esteem were associated 
with greater ND symptoms, while controlling for covariates.  Novelty-seeking and 
perceived academic performance were not associated in the multivariable models.  
Finally, among the substance use indicators, more frequent alcohol use was associated 
with greater ND symptoms, while controlling for covariates.  Cigar/cigarillo use was not 
associated. 
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4. Discussion 
 Accumulating evidence suggests ND symptoms can occur soon after smoking 
initiation (e.g., DiFranza et al., 2007; Gervais et al., 2006).  Intriguingly, cross-sectional 
studies evidence that 4-6% of never-smoking adolescents endorse items measuring ND 
(e.g., Bélanger et al., 2008; Racicot et al., 2011b).  The objective of this study was to 
corroborate and extend previous cross-sectional findings by identifying predictors of ND 
symptoms longitudinally among adolescents who had never smoked a cigarette, not even 
a few puffs.  In the present study, the prevalence of never-smokers endorsing ND 
symptoms (7.8%) was similar to past reports.  Consistent with findings in adolescent 
smokers (e.g., Audrain-McGovern et al., 2007; de Leeuw et al., 2009; Hu et al., 2011), 
socio-demographic indictors, social exposure to smoking, psychosocial indicators, and 
substance use predicted ND symptoms in never-smokers. 
 Age and country of birth were the socio-demographic indicators associated with 
ND symptoms.  Age was inversely associated to ND.  Higher ND symptoms were 
observed in the early survey cycles when adolescents were younger.  Relatedly, 
adolescents who were more likely to endorse ND symptoms commenced smoking earlier, 
and consequently, were excluded at a younger age.  This phenomenon is referred to as the 
“depletion of susceptibles” (Garbe & Suissa, 2005; Karp et al., 2006) whereby in a 
longitudinal cohort of adolescent never-smokers, those who initiate smoking are excluded 
from the sample.  Among participants who began smoking during follow-up, a higher 
proportion was censored in earlier survey cycles compared to later cycles.  Of note, the 
prevalence of adolescents who tried smoking is consistent with national estimates of 
smoking initiation among youth attending 10-12th grades (47.8% vs. 48.2%, respectively; 
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Health Canada, 2008).  Previous research has demonstrated that ND symptoms predict 
smoking uptake in adolescents (O'Loughlin et al., 2009).  Further, attrition does not 
account for the observed age finding; never- and ever-smokers in the entire NDIT cohort 
were followed for the same number of survey cycles.  The other socio-demographic 
indicator, country of birth, was also associated.  Foreign-born participants obtained lower 
ND symptoms scores, regardless of language spoken at home.  It is possible that 
Canadian-born participants were raised in a more “pro-smoking” culture. 
 Social exposure to smoking is a risk factor for ND symptoms in adolescents (e.g., 
Bélanger et al., 2008; Brook et al., 2009; de Leeuw et al., 2009).  Current findings 
corroborated this association as smoking by friends (g=.19) predicted ND symptoms.  
Parental (g=.03) and sibling (g=.01) smoking were not associated.  This result is 
consistent with previous studies showing that the relative influence of family members 
and friends varies by age, with family members having a greater influence in childhood 
and friends having a greater influence in adolescence (e.g., Vitaro, Wanner, Brendgen, 
Gosselin, & Gendreau, 2004).  Social contagion theory (Rowe, Chassin, Presson, 
Edwards, & Sherman, 1992) may explain the observation that never-smokers come to 
believe that they (should) experience cravings when friends talk openly about their 
cravings.  To our knowledge, smoking by school personnel has never been evaluated as a 
risk factor for ND among never-smokers.  Implementing and enforcing smoke-free 
policies in schools should be emphasized as a strategy to prevent the development of risk 
factors for smoking initiation (Barnett et al., 2007). 
 Among psychosocial indicators, depression, stress, self-esteem, and impulsivity 
predicted ND symptoms. Affect control, boredom reduction, and greater social benefits 
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are consequences that never-smoking adolescents expect from smoking cigarettes (Hine, 
Honan, Marks, & Brettschneider, 2007).  Negative affect may predispose adolescents to 
perceive ND symptoms and expect smoking will help curb unpleasant emotions.  Foster, 
Racicot, McGrath (2012) found never-smoking adolescents with clinical levels of 
impulsivity were more likely to believe smoking controls affect and reduces boredom.  
These adolescents are at increased risk of initiating smoking.  In adolescent smokers, 
smoking expectancies have been found to predict eventual ND (Heinz, Kassel, Berbaum, 
& Mermelstein, 2010). 
 When examining psychoactive substances other than cigarettes, alcohol 
consumption predicted ND symptoms (g=.12), which coincides with past findings 
(Racicot et al., 2011b).  This association was probable, given that smoking and alcohol 
use frequently co-occur (Jackson, Sher, & Wood, 2000).  Alcohol use confers greater risk 
for ND in recent onset adolescent smokers (Dierker, Rose, Donny, & Tiffany, 2011).  
Relatedly, alcohol use has been found to increase tolerance to nicotine in mice (Collins, 
Burch, de Fiebre, & Marks, 1988). 
4.1. Limitations 
 There were three limitations of the current study.  First, data were self-reported. 
Although misclassification is possible, self-report is systematically used to measure 
adolescent smoking behavior and it is reliable (Eppel, O'Loughlin, Paradis, & Platt, 
2006).  Future studies should use biomarkers to cross-validate smoking status.  Second, 
schools were selected via convenience sampling, which may limit the generalizability of 
the results.  However, school selection was stratified by population density (i.e., rural, 
suburban, urban) and socioeconomic status (i.e., low, medium, high), as reported by 
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school boards, to maximize external validity.  Third, the non-experimental design of 
NDIT makes causal inference challenging; however, using prospective data permitted the 
evaluation of temporal relationships between ND symptoms and potential predictors. 
4.2. Strengths 
 Strengths of this study also merit consideration.  First, the analytical sample 
(N=847) included a large number of adolescents recruited in secondary schools.  Given 
that adolescence is the developmental stage when individuals are most likely to 
experiment with tobacco (Chassin, Presson, Pitts, & Sherman, 2000), this period was 
optimal for evaluating risk factors for ND.  Second, the measurement definitions of ND 
and never-smoking status were rigorous.  Items measuring ND have been shown to 
possess strong psychometric properties (Bélanger et al., 2008; O'Loughlin, DiFranza, et 
al., 2002).  Never-smoking status was defined conservatively to ensure that participants 
had never smoked cigarettes, not even a puff.  Third, ND predictors were derived from 
validated, standardized scales, which facilitates comparisons across studies.  The wide 
range of predictors were classified into four categories and investigated to depict a 
multifaceted analysis of ND symptoms.  
4.3. Conclusions  
The unexpected phenomenon of ND symptoms among never-smokers has been 
repeatedly observed (cf., Bélanger et al., 2008; DiFranza et al., 2000; O'Loughlin et al., 
2009; Okoli et al., 2009; Prokhorov et al., 2005; Racicot et al., 2011a, 2011b).  This 
longitudinal study replicated previous cross-sectional findings, as peer smoking and 
alcohol use predicted ND symptoms among never-smoking adolescents.  Extending these 
findings, additional predictors of ND, previously only observed among ever-smokers, 
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were identified including socio-demographic indicators (i.e., age, country of birth) and 
psychosocial indicators (i.e., depression, stress, self-esteem, impulsivity).  Further, this 
longitudinal investigation established temporality of exposure whereby indicators 
preceded endorsement of ND symptoms at subsequent time-points.  These findings 
contribute new knowledge regarding the emergence of ND symptoms in never-smoking 
adolescents.  The question remains whether adolescents correctly understand the content 
of these items; however, qualitative work suggests that adolescents conceptually 
distinguish physical addiction (“like an empty spot in the chest”) from mental addiction 
(“I think I can only feel it in my head”; O'Loughlin, Kishchuk, DiFranza, Tremblay, & 
Paradis, 2002, p. 205).  Further psychometric development of the assessment of ND 
symptoms in young never-smokers should consider whether individual items are 
differentially weighted, using an item-response theory framework (e.g., MacPherson, 
Strong, & Myers, 2008), across childhood and adolescence.   
Converging evidence with animal data provide additional support for the 
hypothesis that active smoking is not required to experience ND symptoms and suggest 
neuroadaptations account for somatic withdrawal effects observed in nicotine-naïve rats 
exposed to SHS (Yamada et al., 2010).  Based on the Sensitization-Homeostasis model 
(DiFranza & Wellman, 2005), nicotine exposure through SHS could prime the addiction 
pathway and lead to experiencing ND symptoms (Bélanger et al., 2008).  Recent findings 
support this notion of pharmacological priming.  Brody and colleagues (2011) showed 
that SHS exposure leads to α4β2* nicotinic cholinergic receptor occupancy in non-
smokers, which parallels findings of withdrawal sensations observed in tobacco-naive 
rats exposed to SHS (Small et al., 2010).  Relatedly, it is unclear whether 
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pharmacological exposure to nicotine may partly explain established findings with social 
modeling.  Biomarkers of nicotine and SHS exposure could be used to empirically 
evaluate pharmacological priming as a predictor of ND symptoms.   
Future research should investigate why some participants reporting ND symptoms 
convert to smoking, whereas others may be resilient to smoking uptake despite endorsing 
ND symptoms.  Longer prospective studies are strongly recommended to capture both 
early endorsement of ND symptoms and late smoking onset.  In the present sample, 30% 
who converted to ever-smoking status started smoking within the first three cycles.  
While the current longitudinal study started in 7th grade, it may be prudent to begin 
investigating the emergence of ND symptoms in elementary school.  Some adolescents 
may endorse ND symptoms and resist smoking uptake due to protective factors (e.g., 
extracurricular activities, good relationship with parent; DiFranza et al., 2007), genetic 
differences in nicotine metabolism (Malaiyandi, Sellers, & Tyndale, 2005), or possibly 
perceived risk of SHS exposure (Song, Glantz, & Halpern-Felsher, 2009).  Previous 
research has suggested there may be a class of “late bloomers” who endorse ND 
symptoms, but take a longer period of time before trying smoking (Karp, O'Loughlin, 
Paradis, Hanley, & Difranza, 2005).  Thus, follow-up periods extending into young 
adulthood may be warranted to accurately detect eventual smoking uptake.  Prospective 
studies including additional covariates and employing other analytic strategies (e.g., 
latent growth curve modeling) could help further address this question.  Prevention 
programming should consider ND a novel predictor for adolescent smoking behavior, 
given that ND predicts smoking susceptibility (Okoli et al., 2009) and smoking initiation 
(O'Loughlin et al., 2009).  
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Table 1 
Descriptive Statistics of ND Symptom Predictors at Survey Cycles 1, 10, and 19 
 
 Cycle 1  Cycle 10  Cycle 19 
 M (SD) or %  M (SD) or %   M (SD) or %  
Predictor N = 847  N = 476  N = 325 
Socio-demographics      
- Age (years) 12.7 (.5)  14.8 (.4)  17.0 (.4) 
- Female sex (%) 49.8%  46.6%  46.5% 
- Language spoken at home (%)      
English 58.2%  59.2%  58.8% 
French 22.4%  21.6%  20.3% 
English and French 10.4%  9.0%    9.2% 
Other 9.0%  10.1%  11.7% 
- Born in Canada (%) 91.0%  92.0%  91.7% 
- Family income (% better) 10.8%  18.7%  19.7% 
- Parental education (years) 14.5 (1.4)  14.6 (1.7)  14.6 (2.0) 
Social Smoke Exposure      
- Adult smoking score (0 – 10) 0.5 (.8)  0.3 (.6)  0  .3 (.5) 
- Sibling smokers (number) 0.2 (.5)  0.2 (.6)  0  .2 (.5) 
- Peer smokers (% none) 79.5%  43.3%  32.6% 
- Schoolmates seen smoking  
(% very true) 
89.9%  83.6%  82.5% 
- Teachers seen smoking  
(% very true) 
18.3%  20.4%  18.8% 
Psychosocial Indicators      
- Depression score (0 – 18) 5.9 (3.3)  5.1 (4.3)    6.2 (4.7) 
- Stress score (0 – 45) 4.4 (3.9)  4.0 (4.6)    5.0 (5.1) 
- Poor academic performance  
(% very true) 
59.9%  63.5%  64.9% 
- Self-esteem score (0 – 18) 14.4 (2.5)  14.6 (3.2)  14.9 (3.2) 
- Novelty-seeking score (0 – 36) 15.8 (5.2)  15.8 (6.7)  15.5 (6.7) 
- Impulsivity score (0 – 28) 7.8 (4.2)  7.7 (5.3)    7.7 (5.7) 
Substance Use      
- Cigar or cigarillo use (% never) 99.4%  99.2%  96.9% 
- Alcohol use (% never) 67.1%  56.3%  42.8% 
Note.  M = mean.  SD = standard deviation.  
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Table 2 
GEE Models Predicting ND Symptoms in Adolescent Never-smokers 
 
 Univariate  Multivariable 
Predictor b SE Wald χ2  b SE Wald χ2 Covariates 
Socio-demographics         
- Age -.02 .01 12.31***  -.04 .01 40.84*** Peer smoking, alcohol 
     - Sex        Depression, stress 
Female REF    REF   
Male .08 .03 8.35**  .01 .02 0.11 
     - Language at Home   1.47    1.80 Country of birth, 
parental education English REF    REF   
French -.02 .03 .49  -.01 .03 .05 
English and French -.03 .03 1.04  -.02 .03 .39 
Other .02 .04 .12   .07 .07 1.11 
- Country of Birth        Language at home 
Canada REF    REF   
Other -.08 .03 7.71**  -.11 .04 6.04* 
- Family income  .04 .04 .91  -.03 .04 .48 Stress, self-esteem 
- Parental education .01 .01 .41  .01 .01 .57 Language at home, 
adult smoking 
Social Smoke Exposure         
- Adult smoking .02 .02 .88  .02 .02 1.25 Parental education 
- Sibling smoking .01 .02 .13  .01 .02 .09  
- Peer smoking .09 .02 24.55***  .09 .02 31.10*** Alcohol 
- Schoolmate smoking .00 .04 .00  -.02 .04 .43 Teacher smoking 
- Teacher smoking .03 .02 2.12  .03 .02 3.73* Schoolmate smoking 
Psychosocial Indicators         
- Depression  .02 .00 36.77***  .01 .00 5.15* Stress, self-esteem 
- Stress .03 .00 29.41***  .02 .01 13.19*** Depression, self-
esteem, impulsivity, 
family income 
- Perceived Academic 
  Performance 
-.05 .02 6.41*  -.01 .02 .27 Self-esteem 




- Novelty-seeking .01 .00 16.06***  .00 .00 .03 Impulsivity 
- Impulsivity .01 .00 19.59***  .01 .00 5.28* Novelty-seeking, stress 
Substance Use         
- Cigar or cigarillo .11 .08 1.82  .10 .09 1.30 Alcohol 
- Alcohol .05 .01 12.77***  .04 .01 11.29*** Peer smoking 
Note.  All multivariable models also included age and sex as covariates.   
b = unstandardized beta coefficient.  SE = standard error.  REF = reference category.   
* p ≤ .05; ** p ≤ .01; *** p ≤ .001  
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TRANSITION TO STUDY 2 
 The purpose of Study 1 was to further our understanding of the development of 
ND symptoms among never-smokers, which is, by definition, inconsistent with the 
current conceptualization of ND (APA, 2000). Informed by the determinants of ND 
among smokers, we tested socio-demographic indicators, social exposure to smoking, 
psychosocial indicators, and substance use as longitudinal predictors of ND symptoms in 
a sample of never-smoking adolescents. Peer smoking, a measure of social exposure to 
smoking, emerged as one of the strongest significant predictors of ND symptoms; this is 
congruent with previously published cross-sectional studies demonstrating that peer 
smoking (Bélanger et al., 2008) and number of smokers among family members and 
friends (Racicot et al., 2011a) predict ND symptoms. Despite these data providing 
support for the link between social exposure to smoking and endorsement of ND 
symptoms, the pathway by which they are associated is not fully understood. 
Other researchers have debated the relation between social exposure to smoking 
and ND symptoms, contending that social exposure should not be associated with ND 
among never-smokers, as the latter phenomenon is impossible conceptually. As such, 
they hypothesized that our measures of social exposure raised the possibility that 
adolescents learned to believe they were dependent on nicotine by observing smokers, 
without being “truly” dependent. Relatedly, they recommended that our measures be 
improved to evaluate the relationship between social exposure and ND symptoms more 
validly. 
To test the underlying contribution of social exposure to ND symptoms, we 
evaluated the content of the variables measuring parental, sibling, and peer smoking. This 
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critical analysis led us to the conclusion that our measures of social exposure to smoking 
focused exclusively on the number of smokers among adult family members, siblings, 
and friends. Other measures of social exposure to smoking found in the literature 
typically only assess the prevalence of other smokers (e.g., yes/no for mother/father, 
siblings, peers); the relative frequency of their smoking behavior (e.g., not at all, 
occasionally, regularly, very often; Vitaro et al., 2004); or the ordinal proportion of 
smokers among parents, siblings, or peers (e.g., all, more than half, less than half, hardly 
anybody; de Vries, Engels, Kremers, Wetzels, & Mudde, 2003). Thus, these existing 
measures help determine the identity and the number of smokers in adolescents’ social 
environment without providing additional information about the situational contexts in 
which these smokers use cigarettes. This distinction has potential implications for 
adequately investigating the relation between social exposure to smoking and ND 
symptoms among never-smokers. As an example, one may question whether it is the 
number of friends who smoke that essentially leads to the development of ND symptoms. 
Alternatively, one may question whether observing friends smoking under specific 
circumstance (e.g., smoking at school when anxious and talking openly about cravings) 
is, in fact, what better explains the onset of ND symptoms in a population of never-
smokers. Extending this line of reasoning, could it be possible that reports of ND 
symptoms are situation-specific, whereby never-smoking adolescents experience ND 
symptoms only in the same situations where they observed their friends smoke, but not in 
other situations? Traditional measures of social exposure to smoking, which largely focus 
on smokers’ identity (“who”), would be unable to address that research question. 
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 Social Learning Theory (Bandura, 1977) has often been cited as the predominant 
theoretical framework to explain why observation of smokers in one’s environment is a 
predictor of smoking. Specifically, it is posited that adolescents are more likely to imitate 
the behavior of individuals whom they view as role models, like their parents, siblings, or 
friends. Family members and friends who smoke typically consume cigarettes in a variety 
of contexts, including specific places (e.g. living room, car), under specific circumstances 
(e.g., with others, following meals), and in specific mood states (e.g., relaxed, bored; Van 
Gucht, Van der Bergh, & Vansteenwegen, 2010). However, the majority of research has 
focused almost exclusively on who the smokers are, but has neglected to consider the 
contextual situations in which adolescents observe smokers use cigarettes, that is, the 
“where” and “when”. The cue-reactivity literature (cf. Carter & Tiffany, 1999) has 
evidenced that environmental cues (i.e., contextual situations) are associated with 
smoking behavior among smokers (Conklin, 2006). The repercussions of environmental 
cues in the context of social exposure to smoking remain largely unknown, yet such cues 
could increase the risks associated with smoking initiation. The development of a new 
measure permitting assessment of the contextual situations in which youth observe their 
parents, siblings, and peers smoke would be highly informative. 
Thus, measuring social exposure comprehensively is of paramount importance for 
better understanding the effects of social exposure on smoking precursors and smoking 
behavior. To reach this goal, the objectives of Study 2 were to a) develop an enhanced 
measure of social exposure and examine its psychometric properties, and b) compare the 
predictive ability of this new scale with that of existing measures of social exposure to 
smoking.   








Development and psychometric properties of the Social Smoking Situations (S3) 
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ABSTRACT 
Existing measures of exposure to smoking, such as number of parents, siblings, or friends 
who smoke, fail to capture the contexts in which the exposure occurs. This study 
developed the Social Smoking Situations (S3) Scale to more precisely measure contextual 
exposure to smoking during adolescence. Informed by the cue-reactivity literature and 
using focus groups, items of contextual exposure to smoking were generated for three 
categories of smokers: parents, siblings, and peers. Participants (N = 761; Mage = 15.6, 
SD = 1.3; 61.4% female) were recruited as part of the AdoQuest Study in Montreal, QC. 
Principal components analysis was used to identify the component structure of the 
parental, sibling, and peer versions of the S3 Scale. S3 scores were computed subsequently 
to test their association with smoking behavior and smoking expectancies. Further, S3 
scores were compared with existing measures (i.e., number of smokers) to determine 
which would emerge as a stronger predictor of smoking behavior and smoking 
expectancies. Overall, S3 scores were stronger predictors than existing measures; this 
finding was consistent across the parent (ORavg: 2.59 vs. 1.36), sibling (ORavg: 3.44 vs. 
1.59), and peer (ORavg: 3.89 vs. 1.38) versions. The S3 Scale is a new psychometrically 
sound instrument that may provide a more robust measurement of social exposure to 
smoking during adolescence. Importantly, it has the potential to strengthen prevention 
programming and intervention efforts aimed at adolescents, as it could depict a more 
precise portrait of the individual and contextual sources of social exposure to smoking. 
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INTRODUCTION 
Observing smokers in one’s social environment is a robust predictor of smoking 
during adolescence (Brandon, Herzog, Irvin, & Gwaltney, 2004; Collins & Ellickson, 
2004; U.S. Department of Health and Human Services, 2012). Observing smoking by 
parents, siblings, and peers constitute the predominant sources of exposure to smoking, 
and their influence has been attributed largely to social modeling (cf. Avenevoli & 
Merikangas, 2003; Hoffman, Sussman, Unger, & Valente, 2006; Kobus, 2003; Simons-
Morton & Farhat, 2010; Tyas & Pederson, 1998). Children and adolescents are 2.7 times 
more likely to initiate smoking if parents smoke, 2.3 times more likely if siblings smoke 
(Leonardi-Bee, Jere, & Britton, 2011), and 3.3 times more likely if peers smoke 
(O’Loughlin, Karp, Koulis, Paradis, & DiFranza, 2009).  
Social Learning Theory (Bandura, 1977) posits that adolescents initiate smoking 
by observing and imitating the smoking behavior of role models. In fact, observing 
smoking by others occurs naturally in the social environment under varied circumstances 
(Van Gucht, Van der Bergh, Beckers, & Vansteenwegen, 2010). Thus, exposure to 
smoking constitutes a broader context of observing others and the moments or settings in 
which they smoke. The majority of research that examines social modeling focuses 
predominantly on the role models who smoke (i.e., the “who”), but typically fails to 
consider important contextual situations of exposure to smoking (i.e., the “where” and 
“when”). For example, two adolescents have exactly the same friends who smoke: the 
first sees their friends smoking sporadically at parties, whereas the second sees them 
smoking frequently at school and parties. Existing measures of exposure to smoking 
would code both adolescents as having the same number of friends who smoke, but 
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would overlook the different contextual aspects of exposure to peer smoking. Existing 
measures of exposure to smoking do not adequately capture the contextual situations in 
which role models smoke, which may themselves contribute to the social modeling 
phenomenon. Interestingly, another literature has considered contextual situations and 
how they influence smoking.  
The cue-reactivity literature among smokers (cf. Carter & Tiffany, 1999) has 
identified several contextual situations in which adolescent and adult smokers crave or 
use cigarettes. Common types of smoking situations studied include: locations (e.g., 
home, car, bar/restaurant); activities (e.g., doing chores, being “on the go”, watching 
television, eating, drinking alcohol); social contexts (e.g., smoking with others, at a party, 
with friends); and mood states (e.g., angry, relaxed, bored; cf. Cronk & Piasecki, 2010; 
Dunbar, Scharf, Kirchner, & Shiffman, 2010; Shiffman et al., 2002; Tagmat, Wolff, 
Schumann, John, & Thyrian, 2011; Van Gucht et al., 2010). The cue-reactivity 
framework underscores the pertinence of considering smoking situations when studying 
tobacco use. Tagmat and colleagues (2011) found that adolescents who experienced 
stronger urges to smoke in social situations, negative mood states, and routine situations 
(e.g., waiting for the bus) reported greater daily smoking. Among adult smokers, 
contextual situations including locations, activities, social contexts, and mood states have 
been associated with more cravings (Dunbar et al., 2010) and cigarette smoking (Cronk 
& Piasecki, 2010; Shiffman et al., 2002). Further, Van Gucht and colleagues (2010) 
reported that adult smokers who had greater nicotine dependence consumed cigarettes in 
more locations and during more varied activities. Taken together, the effects of smoking 
situations on smokers have been well established within the cue-reactivity framework. 
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Interestingly, contextual situations may play a parallel role during the emergence of 
adolescents' smoking behavior, depending on where and when youth observe family 
members and peers smoke.  More precise measures of exposure to smoking, by whom, 
where, and in what context may improve our ability to predict adolescent smoking 
uptake. 
The construct of social exposure to smoking encompasses both observing others 
smoking and the contextual situations in which others smoke.  However, existing 
measures of smoke exposure are limited as they narrowly conceptualize exposure to only 
the source of exposure ("who"); they fail to capture the richer topography of social 
exposure to smoking via contextual situations (i.e., “where” and “when”).  Thus, there is 
a need for development of a refined psychometric instrument to more comprehensively 
assess the construct of social exposure to smoking.  It is posited that enhanced assessment 
of broader contextual situations in which adolescents observe others smoking will yield a 
more precise measure of social exposure to smoking.  
The objective of the present study was to develop the Social Smoking Situations 
(S3) Scale to more accurately measure social exposure to smoking among adolescents. 
The approach was twofold.  First, guided by classical measurement theory, the S3 Scale 
and its psychometric properties were developed. Specifically, principal components 
analysis was used in constructing the S3 Scale, while psychometric properties were 
evaluated by testing aspects of convergent and concurrent validity. Second, the S3 Scale 
was tested against existing measures of exposure to smoking (i.e., prevalence of others 
smoking) to predict smoking behavior and smoking expectancies. It was hypothesized 
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that compared to existing measures, the S3 Scale would more strongly predict smoking 
behavior and smoking expectancies among adolescents. 
METHOD 
Development of Item Pool 
Contextual situations of social exposure to smoking were defined as “when” and 
“where” adolescents observe smokers use cigarettes, and “what” the smokers are doing at 
the time of exposure. The item pool was developed in three stages. First, the cue-
reactivity literature was reviewed to empirically inform item development (e.g., Tagmat 
et al., 2011; Van Gucht et al., 2010). Second, separate focus groups were conducted with 
adolescents and young adults whereby they identified any situations in which adolescents 
may observe smoking by their parents, siblings, and peers. Third, independent tobacco 
experts reviewed the items. The number of unique situations identified was 35 for 
parents, 43 for siblings, and 40 for peers; thus, we maintained separate versions for 
parents, siblings, and peers. 
Procedure and Participants 
Adolescents were recruited in 7th, 9th, and 11th grade as part of the AdoQuest 
Study, an ongoing prospective investigation evaluating the natural course of the 
development of smoking behavior in youth (for more information on AdoQuest, please 
see Bélanger et al., (2008); Racicot, McGrath, & O’Loughlin, (2011a)). AdoQuest 
received approval from the institutional review boards of McGill University, Concordia 
University, and Centre de recherche du CHUM. Adolescents who received written 
consent from their parents completed self-report questionnaires, including the parental, 
sibling, and peer versions of the S3 Scale.  For each contextual situation item, adolescents 
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were instructed to rate their current level of exposure to smoking using a three-point scale 
(e.g., “my parents smoke when eating dinner”; 0 = not true, 1 = somewhat true, 2 = very 
true). 
Study 1: Construction of the S3 Scale 
Initial Component Structure and Reduction of the Item Pool 
  An initial Principal Components Analysis (PCA), using varimax rotation and 
Kaiser’s (1960) criterion (eigenvalue ≥ 1), was applied to all items. This approach 
permitted identification of separate components and examination of internal consistency 
within each component. Specifically, PCA yielded a four-component solution on the 
parental version, and five-component solutions for both the sibling and peer versions. To 
maximize internal consistency within each component, the item pool on each version was 
reduced to retain the most salient items that would make the scale most parsimonious and 
practical. Items within each component displaying the highest component loadings and 
highest Cronbach’s alpha were retained. This process led to the retention of 12 parental 
items, 14 sibling items, and 14 peer items, which comprise the final version of the S3 
Scale. 
S3 Scale: Final Version 
PCA with varimax rotation was applied to the final S3 Scale, which revealed that 
the component structure was identical to that obtained with the original, unreduced item 
pool. For the parental version (Table 1), components were labeled: meals (variance = 
21.64%; Cronbach’s α = .90), social activities (20.49%; α = .87), moods (20.29%; 
α = .92), and unpleasant states (19.40%; α = .85); internal consistency was excellent 
(α = .93). For the sibling version, components were labeled: quiet activities (20.11%; α = 
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.92), social activities (18.68%; α = .89), meals (17.56%; α = .92), moods (17.38%; α = 
.95), and belongingness (14.01%; α = .90); internal consistency was excellent (α = .92). 
For the peer version, components were labeled: quiet activities (18.71%; α = .90), moods 
(18.30%; α = .93), social activities (17.22%; α = .86), at school (16.36%; α = .87), and 
belongingness (12.88%; α = .83); internal consistency was excellent (α = .93). 
Study 2: Psychometric Properties of the S3 Scale 
Measures 
S3 Scores. Items within each component of the parent, sibling, and peer versions were 
averaged to compute S3 scores. These scores represent a mean ranging from 0 to 2, 
whereby higher scores indicate greater contextual exposure to smoking. S3 scores were 
also computed using factor scores; results were largely identical (not depicted) and 
averages were preferred to factor scores for practical reasons. 
 
Existing Measures of Exposure to Smoking. Number of parents who smoked and lived in 
the same household as the adolescents was assessed with four separate questions: “Does 
your biological mother / biological father / step-mother / step-father currently smoke 
cigarettes?” Smoking by stepparents was included, as it influences adolescent smoking 
(Fidler, West, van Jaarsveld, Jarvis, & Wardle, 2008). Scores range from 0 to 4 (highest 
number of parents who smoked). Further, participants were asked to write in the exact 
number of siblings, half-siblings, and stepsiblings who smoked and lived with them. 
Similarly, they were asked to write in the exact number of close friends who smoked. 
These questions are consistent with those asked in nationally representative surveys, such 
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as the Canadian Youth Smoking Survey (YSS; Health Canada, 2007) and the U.S. 
National Youth Tobacco Survey (Center for Disease Control and Prevention, 2013). 
 
Smoking Expectancies. The French-language version (Racicot, McGrath, Hine, 
O’Loughlin, & Guyon, 2008) of the Smoking Expectancy Scale for Adolescents (Hine, 
Honan, Marks, & Brettschneider, 2007) was used to measure the expected benefits and 
expected costs of smoking. Using a 10-point scale (0 = Completely unlikely to 9 = 
Completely likely), adolescents rated the likelihood that each expected cost and each 
expected benefit would happen to them. Mean scores were calculated for expected costs 
and benefits.  This scale has excellent internal consistency (costs, α = .94; benefits, α = 
.92; Racicot et al., 2008). Smoking by parents and friends has been found to predict 
smoking expectancies (Hine et al., 2007; Racicot, McGrath, & O’Loughlin, 2011a), 
which in turn, have been associated with prospective smoking (Hine, McKenzie-Richer, 
Lewko, Tilleczek, & Perreault, 2002). 
 
Smoking Behavior. Smoking behavior included questions drawn from the YSS and the 
Canadian Tobacco Use Monitoring Survey (Mills, Stephens, & Wilkins, 1994). 
Specifically, adolescents answered six questions: ever tried a cigarette, even just a few 
puffs (yes/no); ever inhaled cigarette smoke into your lungs (yes/no); ever smoked one 
whole cigarette (yes/no); ever smoked 100 or more whole cigarettes (yes/no); smoking 
frequency (i.e., number of days over the last month where smoking occurred); and 
smoking intensity (i.e., number of cigarettes smoked per day).  
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Analytic Plan 
Data analysis comprised four steps. First, the association between S3 scores and existing 
measures was evaluated to determine the degree of overlap between these measures. 
Second, S3 scores on the parental, sibling, and peer versions were tested as predictors of 
smoking behavior and smoking expectancies. Third, existing measures (i.e., number of 
parents, siblings, and peers who smoked) were also tested as distinct predictors of 
smoking behavior and smoking expectancies, for comparison with the predictability of S3 
scores. Fourth, S3 scores were directly compared with existing measures to determine 




 A total of 761 adolescents completed the S3 Scale. On average, participants were 
aged 15.6 years (SD = 1.3), and the majority was female (61.4%). About half of the 
adolescents reported ever smoking a cigarette even just a few puffs (48.6%), and more 
than a third of the sample endorsed ever inhaling smoke into their lungs (37.4%). A third 
of the adolescents reported ever smoking a whole cigarette (33.3%), while only 15% of 
adolescents endorsed ever smoking more than 100 cigarettes. Participants smoked on 
average 3.55 days (SD = 9.03) over the last 30 days, and smoked 1.16 cigarettes per day 
(SD = 3.38). Adolescents were less likely to endorse benefits of smoking (M = 2.49, SD 
= 1.86) and expected the costs of smoking were more likely to occur to them (M = 5.61, 
SD = 2.01). 
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 Descriptive statistics performed on the S3 scores indicated few adolescents 
identified having no exposure to parental smoking (15.4%, M = .82, SD = .60), sibling 
smoking (20.5%, M =  .61, SD = .50), or peer smoking (9.2%, M = .83, SD = .51), 
irrespective of the contextual situation. This indicates that the vast majority of 
participants endorsed exposure in at least one situation on the S3 scale.  According to 
existing measures, adolescents averaged 1.15 (SD = .82) smoking parents, 1.25 (SD = 
.90) smoking siblings, and 2.52 (SD = 2.69) smoking peers. 
Convergent Validity between Existing Measures and S3 Scale 
Table 2 displays zero-order correlations between S3 scores and existing measures. 
Existing measures were moderately correlated with the S3 total score on the parental 
version (r = .43, p ≤ .001), sibling version (r = .43, p ≤ .001), and peer version (r = .40, p 
≤ .001). Existing measures were also significantly associated with the S3 component 
scores for the parental version (ravg = .36), sibling version (ravg = .31), and peer version 
(ravg = .29). 
Concurrent Validity of S3 Scale 
 S3 total and component scores were significantly associated with ever smoking a 
cigarette; ever inhaling smoke into one’s lungs; ever smoking one whole cigarette; and 
ever smoking more than 100 cigarettes on all three versions (parent, sibling, peer), 
although the component “belongingness” generally was not significantly associated with 
smoking behavior (Table 3). Moreover, the S3 total and component scores (with the 
exception of “belongingness”) were significantly associated with smoking frequency and 
smoking intensity on all three versions (Table 4). Further, with respect to smoking 
expectancies, the S3 scores (total and components) were significantly associated with 
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expected benefits on the parental and peer versions, but not on the sibling version. The 
component “social activities” was consistently associated with expected costs. 
Concurrent Validity of Existing Measures of Exposure to Smoking 
Number of parents who smoked was significantly associated with smoking 
behavior, but not smoking expectancies (Tables 3-4), while number of siblings who 
smoked was significantly associated only with a few indicators of smoking behavior. 
Number of friends who smoked was significantly associated with smoking behavior and 
smoking expectancies.  
Comparison of S3 Scale with Existing Measures of Exposure to Smoking 
 S3 scores generated greater effect size estimates than existing measures when 
predicting smoking behavior on the parental version (Table 3; total S3: ORavg = 2.59; 
components S3: ORavg = 1.88; existing: ORavg = 1.35); the sibling version (total S3: ORavg 
= 3.44; components S3: ORavg = 2.16; existing: ORavg = 1.59); and the peer version (total 
S3: ORavg = 3.89; components S3: ORavg = 2.98; existing: ORavg = 1.38). The total S3 score 
generally exhibited larger standardized beta coefficients than existing measures, except 
for the peer version (Table 4). However, some components on the peer version, such as 
“moods” or “quiet activities”, generated greater effect size estimates than existing 
measures. 
DISCUSSION 
Researchers are learning increasingly about the importance of considering 
contextual situations when measuring social exposure to smoking and predicting smoking 
initiation among adolescents. In fact, existing measures fail to capture the contextual 
situations in which adolescents are exposed to smoking in their social environment. 
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Consistent with findings from the cue-reactivity framework, several of the 
components identified on the S3 Scale were largely similar to the situations in which 
smokers report cravings or using cigarettes. Examples of such situations include social 
activities, mood states, meals, or quiet activities, suggesting that our scale has the ability 
to capture the situations in which smokers themselves reported smoking in previous 
studies. Further, analyses of convergent validity showed that the strength of association 
between S3 scores and existing measures was moderately high. This implies that S3 scores 
and number of smokers both measure a theoretically related construct, namely, social 
exposure to smoking. The fact that their strength of association was not excessively high, 
however, suggests that S3 scores and existing measures capture unique aspects of social 
exposure to smoking. As such, present findings provide support for our conceptualization 
such that existing measures are mostly smoker-centric (i.e., “who is smoking”), whereas 
the S3 Scale broadens the construct to include contextual situations of exposure (i.e., 
“where” and “when” are adolescents observing their parents, siblings, and friends 
smoke). 
Analyses of concurrent validity showed that globally, adolescents exposed to 
smoking in more situations were more likely to be smokers, smoked more frequently and 
with greater intensity, and held more positive beliefs about smoking. Most importantly, 
S3 scores were generally more strongly associated with smoking behavior and smoking 
expectancies than existing measures on all three versions of the S3 Scale, which suggests 
the latter represents a potent alternative when measuring social exposure to smoking. 
This study corroborates and extends previous findings that situations of smoke exposure 
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predict greater smoking susceptibility in adolescent never-smokers (Racicot et al., 
2011a).  
Present findings provide support to the hypothesis that the S3 Scale is a novel, 
psychometrically sound instrument designed to more precisely assess contextual 
exposure to smoking. Okoli, Browning, Rayens, and Hahn (2008) contend that the 
relation between social exposure to smoking and smoking behavior can be explained by 
two theoretical frameworks: social modeling (e.g., Krohn, Skinner, Masey, & Akers, 
1985) and cue-reactivity (e.g., Caggiula et al., 2001). Given that adolescents complete the 
S3 Scale for targeted role models, the scale encompasses elements of social modeling, 
such as observational learning of said role models. Moreover, the S3 Scale captures 
elements of the cue-reactivity framework, given that contexts are environmental cues 
(Conklin, 2006). Observing one’s father smoke after he has eaten a meal provides 
different contextual cues from when he is smoking while he is stressed, which may have 
different repercussions on the observing adolescent. In fact, this study highlighted that 
not all types of situations were equal. As an example, “social activities” emerged as a 
much stronger component than “belongingness”.   
Study Limitations 
 First, the cross-sectional nature of this study does not permit assessment of 
temporality. Second, S3 items do not measure the intensity or duration of exposure. 
Nicotine monitors (Hammond & Leaderer, 1987) could be used in future studies to 
objectively obtain these data. Third, the S3 measures contextual situations in which 
adolescents are exposed to cigarette smoking only. Although enquiring about other 
tobacco products would have been informative, cigarettes remain by far the most popular 
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(Health Canada, 2007). Fourth, this study used a full-sample design to validate the S3 
Scale; future studies should replicate the current findings with a larger sample, including 
a holdout sample. Fifth, the S3 Scale is limited to social exposure to parental, sibling, and 
peer smoking. Additional versions could be developed to more comprehensively assess 
contextual exposure to smoking, including other family members, strangers in public 
places, or social media.  
Implications and Recommendations for Future Research 
 From a methodological perspective, the S3 Scale may be used as an alternative to 
existing measures to more precisely capture contextual exposure to smoking. Researchers 
may opt to examine the effects of the total S3 scores or look at the effects of each 
individual component on smoking behavior during adolescence. Longitudinal research 
should test whether S3 scores predict key smoking behavior milestones. Moreover, 
momentary ecological assessment (Shiffman, 2009) could be used to explore the degree 
of concordance between situations in which adolescents report exposure to smoking and 
situations in which parents, siblings, and friends report smoking. 
From a public health perspective, this new, enhanced scale has the potential to 
strengthen prevention efforts targeting youth, as it could depict a more precise portrait of 
social exposure to smoking. Specifically, situations of smoke exposure known to be 
strongly associated with smoking could be depicted purposefully in media campaigns. 
Classroom interventions could address the situations in which adolescents observe 
smokers and emphasize the negative consequences of smoke exposure on smoking-
related beliefs and eventual smoking. Relatedly, future research should examine the 
situations in which adolescents initiate cigarette smoking themselves. If these situations 
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are consistent with the ones in which they previously observed smokers, prevention 
programs could target specific situations of smoke exposure for better prevention of 
smoking uptake. 
Conclusions 
 The development of the S3 Scale and its psychometric properties was conducted 
to gain greater insight about the nature and repercussions of contextual situations of 
youth’s exposure to smoking. The parental, sibling, and peer versions displayed excellent 
internal consistency and were significantly associated with smoking behavior and 
expected benefits. Compared with existing measures, S3 scores were typically more 
strongly associated with smoking behavior and expected benefits, suggesting they are 
better predictors. Present findings suggest that the S3 Scale is a brief, psychometrically 
sound instrument that could be used as an alternative to existing measures when assessing 
contextual exposure to smoking and statistically modeling adolescent smoking behavior. 
Thus, prevention programming should not only target who is smoking around 
adolescents, but also in which situations. 
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Table 1 
     
Component Loadings on the Parental, Sibling, and Peer Versions of the S3 Scale 
 Component loadings 
Parental Items:  
They smoke (when)… 
Social 
activities Moods Meals 
Unpleasant 
states - 
at a party .85 .24 .18 .15 - 
in a group .79 .33 .19 .22 - 
having guests .74 .28 .15 .35 - 
in a calm situation .31 .81 .24 .30 - 
in a happy situation .35 .76 .21 .32 - 
in a boring situation .35 .76 .22 .31 - 
eating dinner .17 .18 .89 .10 - 
eating lunch .20 .14 .87 .19 - 
eating breakfast .10 .19 .84 .20 - 
doing housework .29 .13 .20 .77 - 
sick .17 .38 .17 .77 - 
having physical pain .21 .39 .20 .75 - 
Sibling Items:  
They smoke (when)… 
Social 





at a party .91 .17 .16 .10 .09 
drinking alcohol .82 .25 .19 .20 .06 
in a group .78 .30 .13 .06 .29 
in a calm situation .26 .82 .28 .30 .10 
in a happy situation .33 .78 .29 .28 .16 
in a boring situation .37 .77 .31 .21 .16 
eating lunch .22 .24 .84 .21 .20 
eating dinner .21 .35 .82 .24 .04 
eating breakfast .14 .21 .74 .44 .21 
studying .10 .18 .16 .87 .18 
reading .13 .17 .26 .86 .05 
doing homework .14 .25 .25 .84 .15 
wanting to be part of a group .13 .10 .14 .15 .92 
wanting to impress others  .17 .14 .13 .13 .91 
Peer Items:  









in a group .78 .19 .32 .14 .27 
using drugs .77 .23 .15 .14 .26 
at a party .77 .27 .30 .10 .14 
in a sad situation .19 .84 .26 .28 .12 
in a stressful situation .32 .81 .25 .26 .08 
in an infuriating situation .25 .79 .30 .29 .07 
during recess  .24 .24 .79 .21 .09 
after school .44 .26 .75 .17 .06 
before going to school .20 .32 .74 .31 .06 
on the computer .12 .20 .14 .90 .12 
watching TV .10 .19 .20 .87 .06 
talking on the phone .14 .33 .23 .78 .13 
wanting to impress others .22 .07 .04 .08 .89 
wanting to be part of a group .20 .08 .09 .14 .88 
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Table 2 
Zero-order Correlations of S3 Scores and Existing Measures of Exposure to Smoking 
   
Parental version  1 2 3 4 5 6  
1. Smokers (Parents) a  -       
2. S3 Score (Total)  .43 ** -      
3.  Social activities  .43** .84** -     
4.  Moods  .39** .89** .71** -    
5.  Meals  .21** .73** .44** .50** -   
6.  Unpleasant 
activities 
 .39** .84** .61** .72** .47** -  
         
Sibling version  1 2 3 4 5 6 7 
1. Smokers (Sibling) a  -       
2. S3 Score (Total)  .43** -      
3.  Social activities  .40** .78** -     
4.  Moods  .39** .88** .64** -    
5.  Meals  .30** .84** .48** .68** -   
6.  Belongingness  .25** .59** .37** .38** .38** -  
7.  Quiet activities    .22* .74** .36** .57** .61** .35** - 
         
Peer version  1 2 3 4 5 6 7 
1. Smokers (Friends) a  -       
2. S3 Score (Total)  .40** -      
3.  Social activities  .32** .82** -     
4.  Moods  .32** .80** .60** -    
5.  At school  .30** .78** .65** .68** -   
6.  Belongingness  .15** .57** .51** .28** .26** -  
7.  Quiet activities  .34** .72** .41** .60** .54** .29** - 
Note. a = Existing measures of exposure to smoking 
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Table 3          
Binary Logistic Regression Estimates for Smoking Behavior  
  
Ever tried a cigarette  
Ever inhaled smoke 
into your lungs  
Ever smoked one 
whole cigarette  
Ever smoked 100 or 
more cigarettes 
Predictor variable  OR  (95%, CI)  OR  (95%, CI)  OR  (95%, CI)  OR  (95%, CI) 
Parental version             
S3 score (Total)  2.35   (1.77, 3.12)***  2.37  (1.76, 3.18)***  2.32  (1.71, 3.14)***  3.32  (2.13, 5.17)*** 
Social activities  1.82 (1.46, 2.29)***  1.76 (1.39, 2.23)***  1.83 (1.43, 2.35)***  2.45 (1.66, 3.61)*** 
Moods  1.84 (1.48, 2.30)***  1.85 (1.47, 2.33)***  1.86  (1.46, 2.37)***  2.42 (1.70, 3.46)*** 
Meals  1.72  (1.37, 2.17)***  1.83 (1.45, 2.31)***  1.76 (1.39, 2.23)***  2.11 (1.53, 2.91)*** 
Unpleasant 
activities 
 1.69 (1.33, 2.15)***  1.69 (1.32, 2.14)***  1.57 (1.23, 2.01)***  1.90 (1.35, 2.66)*** 
Smokers (parents) a  1.23  (1.01, 1.50)*  1.28  (1.04, 1.57)*  1.36  (1.09, 1.68)**  1.54  (1.16, 2.06)** 
Sibling version             
S3 score (Total)  3.31  (1.91, 5.72)***  4.10  (2.37, 7.09)***  2.64  (1.57, 4.44)***  3.69  (1.95, 6.97)*** 
Social activities  2.07 (1.48, 2.90)***  2.20 (1.54, 3.13)***  1.82 (1.28, 2.59)***  2.80 (1.63, 4.81)*** 
Moods  2.29 (1.59, 3.29)***  2.72 (1.88, 3.93)***  2.02 (1.41, 2.88)***  2.54 (1.61, 4.01)*** 
Meals  1.73 (1.20, 2.50)**  2.13 (1.48, 3.06)***  1.59 (1.12, 2.26)**  1.83 (1.20, 2.80)** 
Quiet activities  2.44 (1.42, 4.20)***  2.65 (1.62, 4.35)***  1.85 (1.18, 2.90)**  1.93 (1.17, 3.18)** 
Belongingness  1.06   (.63, 1.79)  1.01   (.58, 1.76)  1.37   (.79, 2.38)  2.15 (1.11, 4.19)* 
Smokers (siblings) a  1.68  (1.07, 2.62)*  1.53  (1.00, 2.33)*  1.55  (1.00, 2.39)*  1.47    (.88, 2.47) 
Peer version             
S3 score (Total)  3.18  (2.23, 4.54)***  3.71  (2.60, 5.29)***  3.29  (2.32, 4.66)***  5.37  (3.47, 8.30)*** 
Social activities  2.12 (1.53, 2.94)***  2.29 (1.62, 3.26)***  2.39 (1.66, 3.43)***  3.79 (2.01, 7.13)*** 
Moods  2.19 (1.75, 2.74)***  2.49 (1.99, 3.13)***  2.26 (1.81, 2.83)***  3.84 (2.80, 5.28)*** 
At school  2.42 (1.90, 3.08)***  2.81 (2.19, 3.61)***  2.47 (1.93, 3.16)***  5.65 (3.72, 8.59)*** 
Quiet activities  3.10 (2.24, 4.29)***  3.34 (2.48, 4.50)***  2.75 (2.09, 3.62)***  3.68 (2.77, 4.89)*** 
Belongingness    .94 (.74, 1.18)    .92 (.73, 1.16)  1.04   (.82, 1.31)    .97   (.74, 1.28) 
Smokers (friends) a  1.39  (1.27, 1.53)***  1.41  (1.29, 1.54)***  1.39  (1.28, 1.51)***  1.31  (1.22, 1.41)*** 
Note. a = Existing measures of exposure to smoking. OR = Odds ratio; CI = Confidence interval. 
        *p ≤ .05; ** p ≤ .01; ***p ≤ .001. 	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Table 4                 
Linear Regression Estimates for Smoking Behavior and Smoking Expectancies 
  Measures of smoking behavior  Smoking expectancies 
  Smoking frequency  Smoking intensity  Expected benefits  Expected costs 
Predictor Variable  β t η2  β t η2  β t η2  β t η2 
Parental version                 
S3 Score (Total)  .20 5.02*** .04  .19 4.64*** .04  .13 3.08** .02  .06 1.50 .00 
Social activities  .18 4.55*** .03  .17 4.27*** .03  .12 3.04** .02  .14 3.47*** .02 
Moods  .21 5.15*** .04  .19 4.77*** .04  .11 2.81** .01  .04      .91 .00 
Meals  .11 2.62** .01  .11 2.73** .01  .09 2.25* .01  -.01     -.23 .00 
Unpleasant 
activities 
 .17 4.19*** .03  .14 3.49*** .02  .08 2.01* .01  .03      .73 .00 
Smokers (parents) a  .18 4.30*** .03  .16 23.87*** .03  -.01  -.20 .00  .00      .05 .00 
Sibling version                 
S3 Score (Total)  .19 3.21*** .04  .21 3.42*** .04  .10 1.64 .01  .09 1.43 .01 
Social activities  .13 2.14* .02  .13 2.20* .02  .05      .73 .00  .14 2.28* .02 
Moods  .27 4.53*** .07  .27 4.63*** .08  .09 1.47 .01  .10 1.54 .01 
Meals  .14 2.26* .02  .16 2.55** .02  .08 1.25 .01  .07 1.08 .00 
Quiet activities  .12 2.01* .02  .12 1.99* .02  .11 1.71 .01  .02      .25 .00 
Belongingness  .02    .25 .00  .06     .72 .00  .16 1.95 .02  -.01    -.08 .00 
Smokers (siblings) a  .11  1.20 .01  .07     .73 .01  .10 1.06 .01  .11 1.18 .01 
Peer version                 
S3 Score (Total)  .31 7.85*** .10  .31 7.86*** .10  .21 5.27*** .05  .06 1.40 .00 
Social activities  .20 3.67*** .04  .19 3.59*** .04  .22 4.04*** .05  .21 4.01*** .05 
Moods  .36 9.23*** .13  .35 8.91*** .12  .23 5.67*** .05  .06 1.34 .00 
At school  .36 9.22*** .13  .33 8.45*** .11     .22 5.49*** .05  .07 1.74 .01 
Quiet activities  .41 10.86*** .17  .41 10.82*** .17  .20 4.98*** .04  -.03    -.71 .00 
Belongingness  -.08 -1.88 .01   -.05 -1.18 .00  .05 1.14 .00  .08 2.02* .01 
Smokers (friends) a  .32 8.04*** .10  .34 8.41*** .11  .20 4.75*** .04  -.08 -1.99* .01 
Note. a = Existing measures of exposure to smoking. β = standardized beta coefficient; η2 = eta squared, estimate of effect size. 
       *p ≤ .05; ** p ≤ .01; ***p ≤ .001. 
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TRANSITION TO STUDY 3 
 The aim of Study 2 was to develop a refined psychometric instrument to measure 
and evaluate the effects of the situational contexts in which adolescents observe their 
parents, siblings, and peers smoke. Traditionally, such contexts have been overlooked by 
existing measures of social exposure to smoking (i.e., who is smoking, how many people 
are smoking), which largely focus on social modeling as their theoretical approach. 
Informed by the cue-reactivity framework which investigates the effects of smoking cues 
(e.g., ashtrays) on smokers, we postulated that the contextual cues in which social 
exposure to smoking occurs (e.g., witnessing parents smoke after a meal) could, in and of 
themselves, contribute to greater smoking risk. Consequently, we hypothesized that the 
S3 Scale would permit a more comprehensive assessment of social exposure, as it 
encompasses elements of both social modeling and cue-reactivity frameworks.  
As expected, the S3 Scale was found to be more strongly associated with 
indicators of smoking behavior and smoking expectancies than the more narrowly 
focused, existing measures. Consistent with our hypotheses, the S3 Scale generated larger 
estimates of effect size. This finding supports the proposition that the S3 Scale measures 
the broader context of observing smokers and the many circumstances under which they 
smoke cigarettes, and that such contextual cues add to social exposure to smoking as a 
theoretical concept. Consequently, findings from Study 2 strongly suggest the S3 Scale is 
an enhanced, more optimal instrument that allows for more precise measurements of 
social exposure to smoking and its effects on smoking behavior during adolescence. 
When adolescents observe significant others smoke cigarettes, they engage not 
only in social learning within specific situational contexts, but they also inhale doses of 
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nicotine from SHS exposure. Epidemiological data have shown that SHS exposure can 
yield concentrations of nicotine in nonsmokers that are similar to those observed in some 
smokers (Al-Delaimy et al., 2001; Dimich-Ward et al., 1997). Notably, nicotine is known 
to have psychoactive effects on the central nervous system of smokers (Henningfield & 
Heishman, 1995), and nonsmokers inhaling SHS have been found to absorb 
concentrations of nicotine in levels known to have psychotropic responses in actual 
smokers (Pacifici et al., 1995; Perkins et al., 2001). Interestingly, an increasing number of 
researchers are beginning to consider that pharmacological exposure to nicotine from 
SHS (Becklake et al., 2005; Okoli, Rayens, & Hahn, 2007; Racicot et al., 2011a) could 
constitute a unique risk factor for adolescent smoking. As such, a plausible physiological 
pathway linking pharmacological exposure to nicotine during childhood and adolescence 
with subsequent smoking initiation has been proposed (Anthonisen & Murray, 2005). To 
test this hypothesis, we previously examined the differential effects of pharmacological 
and social exposure on precursors to smoking in a sample of never-smoking adolescents 
(Racicot et al., 2011a). Number of smokers among parents, siblings, and friends, but not 
salivary cotinine, was associated with smoking expectancies, ND symptoms, and 
smoking susceptibility. We discussed that low levels of pharmacological exposure 
observed in our sample, and using only one biomarker type (cotinine) could explain that 
pharmacological exposure did not significantly predict smoking precursors. 
In spite of the non-significant finding for pharmacological exposure, we remained 
curious about the possibility of a physiological pathway between nicotine exposure from 
SHS and smoking behavior during adolescence, yet we were aware that testing that 
research question via the experimental approach would have posed serious ethical 
	   58 
challenges. The goal of Study 3 was to evaluate the differential relations of 
pharmacological and social exposure to smoking with the development of precursors to 
smoking. We tested our newly developed S3 Scale (i.e., an enhanced measure of social 
exposure to smoking) against three objective pharmacological measures of nicotine 
exposure (i.e., salivary cotinine, hair nicotine, and passive nicotine monitor) to predict six 
smoking precursors: expected benefits, expected costs, temptations to try smoking, 
aversion to SHS exposure, smoking susceptibility, and ND symptoms.  








Is nicotine the smoking gun? The effects of pharmacological exposure to nicotine 







Racicot, S., & McGrath, J.J. (Under Review) 
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ABSTRACT 
Social exposure to smoking, or observing smokers in one’s environment, is a well-
established predictor of smoking behavior during adolescence. Emerging evidence 
suggests that pharmacological exposure to nicotine from secondhand smoke (SHS) is also 
associated with smoking behavior. This study investigated whether pharmacological 
exposure to smoking uniquely predicts greater risk for smoking initiation among 
adolescent never-smokers. Participants included 338 never-smokers (Mage=12.9, SD= 0.4; 
53% female) who answered questions about their social exposure to smoking (i.e., 
situations of SHS exposure derived from the Social Smoking Situations (S3) Scale), and 
known smoking precursors (i.e., expected benefits and costs, temptations to try smoking, 
aversion to SHS, smoking susceptibility, ND symptoms). Saliva and hair samples were 
collected to derive pharmacological measures of cotinine and nicotine. Participants also 
wore a monitor to measure airborne nicotine. Greater pharmacological exposure was 
significantly associated with greater expected benefits (p = .018) and lower expected 
costs (p = .026). Greater social exposure was significantly associated with greater 
temptations to try smoking (p = .005), lower aversion to SHS exposure (p = .001), and 
greater smoking susceptibility (p ≤ .001). Finally, greater social exposure was 
significantly associated with greater ND symptoms, but only in the presence of greater 
pharmacological exposure (p ≤ .001). This study is the first to reveal that nicotine 
exposure from SHS poses a risk for developing smoking precursors.  
  
	   61 
INTRODUCTION 
 In spite of numerous anti-tobacco campaigns, more than half of North American 
children (53.6%) continue to be exposed to secondhand smoke (SHS; Centers for Disease 
Control and Prevention, 2010). SHS has been associated with deleterious health 
repercussions during childhood, including infections (e.g., ear infections, bronchitis, 
pneumonia), respiratory problems (e.g., asthma, coughing, sneezing), sudden infant death 
syndrome (U.S. Department of Health and Social Services [USDHHS], 2006), and 
neurobehavioral disorders (e.g., ADHD, learning disability; Kabir, Connolly, & Alpert, 
2011). However, emerging evidence suggests that SHS exposure is also associated with 
smoking behavior during adolescence, and this association could be explained by nicotine 
exposure (Anthonisen & Murray, 2005). In fact, nicotine, the main psychotropic 
substance in tobacco (USDHHS, 1988), has been associated with nicotine dependence 
(ND) in humans (Henningfield & Heishman, 1995; Stolerman & Jarvis, 1995), 
sensitization in animals (Vezina, McGehee, & Green, 2007), and is present in SHS 
(Okoli, Kelly, & Hahn, 2007). 
SHS Exposure in Smokers 
Extant literature focusing on smokers indicates that SHS exposure confers greater 
risk for continued smoking and ND symptoms, over and above that of one’s own active 
smoking behavior. Among adults, SHS exposure at home and in an automotive vehicle 
has been associated with a lower likelihood of contemplating cessation and attempting to 
quit, and a greater likelihood of reporting ND symptoms (Okoli, Browning, Rayens, & 
Hahn, 2008; Wilson-Frederick et al., 2011). Among adolescents, number of days where 
SHS exposure occurred at home has been associated with a greater likelihood of smoking 
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upon awakening in the morning and smoking more cigarettes daily, and lower odds of 
attempting to quit and ceasing smoking (Wang, Ho, Lo, & Lam, 2012, 2013). 
Specifically, SHS exposure at home partially mediated the relation between smoking by 
family members with smoking in the morning, daily cigarette consumption (Wang et al., 
2012), and smoking cessation (Wang et al., 2013). Such findings indicate that even 
among smokers, nicotine exposure through SHS seems to represent a distinctive and 
additive risk factor for continued smoking and ND. 
Exposure to SHS and Nicotine Intake in Nonsmoking Populations 
In addition to conferring greater risk for smoking, SHS exposure has an impact on 
nonsmoking populations. Nonsmokers exposed to SHS inhale large amounts of its 
nicotine, namely, between 60 and 80% (Iwase, Aiba, & Kira, 1991). When comparing 
smokers with nonsmokers exposed to SHS at work, the concentration of nicotine 
measured in hair samples was largely comparable (1.2 vs. 1.0 ng/mg: Dimich-Ward, Gee, 
Brauer, & Leung, 1997; 7.9 vs. 6.7 ng/mg: Al-Delaimy, Fraser, & Woodward, 2001). 
Nonsmokers living with a nonsmoking spouse were found to have lower hair nicotine 
values than those whose spouse smoked outside the home only (0.3 vs. 0.5 ng/mg; Yoo et 
al., 2010), suggesting that even low exposure matters. An experimental study indicated 
that youth are more affected by SHS exposure than adults. After exposing nonsmoking 
children and nonsmoking adults to the same amounts of SHS, children exhibited a higher 
dose of nicotine than adults not only immediately after the exposure, but also one week 
later (Willers, Skarping, Dalene, & Skerfving, 1995). Importantly, these studies 
demonstrate that nonsmokers exposed to SHS absorb high doses of nicotine. 
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Pacifici and colleagues (1995) reported blood nicotine concentrations in 
nonsmokers that, at the same concentration, produce psychotropic effects in smokers 
(Perkins, Fonte, Sanders, Meeker, & Wilson, 2001). Recently, neuroimaging findings in 
young adults have revealed that smokers and nonsmokers exposed to SHS do not differ 
with respect to the occupancy of α4β2 nicotinic acetylcholine receptors (nAChRs) in the 
thalamus, brainstem, or cerebellum (Brody et al., 2011). Similarly, SHS exposure leads to 
greater density of α7 nAChRs in the stratum oriens and CA2/3, and non-α7 nAChRs in 
the dentate gyrus and thalamus of nicotine-naive rats (Small et al., 2010). Altogether, 
these findings suggest that nonsmokers can absorb similar quantities of nicotine when 
compared to smokers, and neuroimaging studies provide convincing evidence that such 
exposure has neuronal effects. Given that nicotine has deleterious effects on the 
developing brain of children and adolescents (cf. Slotkin, 2002), they represent a 
population that is particularly vulnerable to the effects of SHS exposure.  
SHS Exposure and Smoking Behavior Milestones 
Consistent with the literature showing that nonsmokers absorb non-negligible 
doses of airborne nicotine, SHS exposure has been identified as a risk factor for the onset 
of smoking behavior milestones. SHS exposure (i.e., number of days exposed at home, 
inside a car) has been associated with smoking in the past month and established smoking 
(Seo, Bodde, & Torabi, 2009), as well as ever smoking (Glover et al. 2011). The latter 
study showed that after adjusting for self-reported SHS exposure, parental smoking was 
no longer a significant predictor of ever smoking. Further, Wang, Ho, and Lam (2011) 
showed that exposure to parental smoking and SHS exposure at home (number of days 
where exposure occurred) predicted smoking initiation two years later. Follow-up 
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analyses revealed that SHS exposure partially mediated the relation between parental 
smoking and smoking initiation. Thus, these studies suggest that SHS exposure can act as 
a mediator or explain the relation between social exposure to smoking (e.g., parental 
smoking) and smoking behavior. However, these studies measured self-reported SHS 
exposure, but not pharmacological exposure to nicotine from SHS. 
SHS Exposure in Never-Smokers: Evidence for Precursors to Smoking 
 SHS exposure has been identified as a risk factor not only for smoking behavior 
per se, but also for smoking precursors among never-smokers. Precursors to smoking are 
risk factors that develop prior to smoking initiation and are known to influence initiation, 
such as smoking susceptibility or smoking expectancies (cf. Racicot, McGrath, & 
O’Loughlin, 2011a). SHS exposure at home or in a vehicle has been shown to contribute 
to greater smoking susceptibility among adolescent never-smokers (Seo, Torabi, & 
Weaver, 2008). Experiencing an “unpleasant or gross” sensation during SHS exposure 
emerged as a protective factor against smoking susceptibility, whereas liking the smell of 
smoke was a risk factor for smoking susceptibility among preadolescent never-smokers 
(Lessov-Schlaggar, Wahlgren, Liles, Ji et al., 2011; Lessov-Schlaggar, Wahlgren, Liles, 
& Jones et al., 2011). Moreover, Bélanger et al. (2008) showed that SHS exposure 
predicted endorsement of ND symptoms among never-smoking 5th graders, even after 
adjusting for smoking by siblings and peers. Similarly, nicotine-naïve rats exposed to 
SHS exhibited behaviors consistent with withdrawal symptoms in animals (Small et al., 
2010; Yamada et al., 2010). Thus, SHS exposure has been shown to contribute to 
smoking susceptibility and ND symptoms, which are known risk factors for smoking 
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initiation (Pierce, Choi, Gilpin, Parkas, & Merritt, 1996; O’Loughlin, Karp, Koulis, 
Paradis, & DiFranza, 2009). 
Pharmacological Exposure to Nicotine from SHS and Greater Risk for Smoking 
SHS exposure is frequently measured as the number of days (e.g., Wang et al., 
2011) or the number of places where the exposure occurs (e.g., home vs. car; Okoli, 
Rayens, & Hahn, 2007), using self-report questions. Due to improvements in technology 
permitting greater ease of objective measurement of SHS exposure, researchers are 
relying increasingly on biomarkers of pharmacological exposure to nicotine through SHS 
(Jaakkola & Jaakkola, 1997). Upon entering the body, nicotine is mainly metabolized 
into cotinine, which can be found in bodily fluids like blood, saliva, and urine (Benowitz, 
1996). Salivary cotinine is a biomarker that provides a short-term estimate of nicotine 
exposure over the last 2-4 days in children, given that its half-life ranges from 32 to 82 
hours in that population (Jaakkola & Jaakkola, 1997). On the other hand, hair nicotine is 
a biomarker that provides long-term measurement of nicotine exposure, given that each 
centimeter of hair represents an estimate of nicotine exposure over the last 30 days (Al-
Delaimy, 2002). 
An increasing number of researchers are using nicotine biomarkers. Becklake, 
Ghezzo, and Ernst (2005) found that salivary cotinine measured in nonsmoking children 
predicted smoking initiation four years later, even after adjusting for the number of 
smokers at home. Further, Okoli, Rayens, and Hahn (2007) showed that adult 
nonsmokers with higher hair nicotine values were 2.2 times more likely to endorse four 
or more DSM-IV nicotine withdrawal symptoms. Thus, these studies provide 
preliminary, compelling evidence that pharmacological exposure to nicotine may 
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contribute to smoking behavior. Using salivary cotinine biomarkers, Racicot, McGrath, 
and O’Loughlin (2011a) studied the effects of pharmacological exposure to nicotine on 
precursors to smoking initiation among never-smoking adolescents. Salivary cotinine did 
not significantly predict smoking precursors, which was largely attributable to the low 
levels of SHS exposure observed in the sample. 
Social Exposure to Smoking 
 Observing smoking by parents, siblings, and peers across different contextual 
situations in youth’s social environment has been referred to as social exposure to 
smoking (Racicot, Drouin, & McGrath, 2014), and is a robust, consistent predictor of 
smoking during adolescence (Leonardi-Bee, Jere, & Britton, 2011; O’Loughlin et al., 
2009). Social Learning Theory (Bandura, 1977) posits that adolescents observe and 
imitate the smoking behavior of role models, and its effects have been documented for 
the past few decades (e.g., Krohn, Skinner, Massey, & Akers, 1985). Recently, 
researchers have begun to acknowledge that observing smokers may lead not only to 
greater social exposure to smoking (i.e., observing who is smoking, where, and when), 
but also greater pharmacological exposure to nicotine through SHS (i.e., inhaling and 
absorbing airborne nicotine). According to this conceptualization, it is imperative to 
simultaneously measure social exposure to smoking and pharmacological exposure to 
nicotine through SHS to evaluate their independent effects on smoking precursors.  
The Present Study 
Extending our earlier work (Racicot et al., 2011a), this study evaluated the 
differential effects of social exposure to smoking (i.e., contextual situations of parental, 
sibling, and peer smoking) and pharmacological smoke exposure (i.e., salivary cotinine, 
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hair nicotine, and nicotine monitor) on smoking precursors in a sample of adolescent 
never-smokers. Smoking precursors were selected purposefully due to their established 
relations with smoking behavior. Specifically, smoking expectancies develop prior to 
smoking initiation (Foster, Racicot, & McGrath, 2012) and contribute to prospective 
smoking (Hine, McKenzie-Richer, Lewko, Tilleczek, & Perreault, 2002). Aversion to 
SHS exposure has been associated with a greater likelihood of having a home smoking 
ban (Martinez-Donate et al., 2007), which in turn, has been associated with a lower 
likelihood of smoking initiation (Emory, Saquib, Gilpin, & Pierce, 2010). ND symptoms 
among adolescent never-smokers (Racicot, McGrath, Karp, & O’Loughlin, 2013) 
predicted first cigarette puff and onset of daily smoking in a 5-year longitudinal study 
(O’Loughlin et al., 2009) Smoking susceptibility is a well-established predictor of 
smoking initiation among never-smoking adolescents (Pierce et al., 1996). Further, 
smoking susceptibility has been associated with social exposure to smoking (Racicot et 
al., 2011a), and sensitivity to SHS exposure (Lessov-Schlaggar, Wahlgren, Liles, Ji et al., 
2011) among never-smoking youth. The present study tested two specific hypotheses. 
First, it was hypothesized that after adjusting for social exposure to smoking, greater 
pharmacological exposure to nicotine from SHS would remain the only significant 
predictor associated with greater smoking precursors. Second, it was hypothesized that 
greater social exposure to smoking would predict greater smoking precursors, but only in 
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METHOD 
Participants 
 Adolescents (N = 406; 52.5% females; Mage = 13.0 years, SD = 0.5) attending 
secondary schools within the greater Montreal area participated in AdoQuest, a 
longitudinal cohort study designed to examine the development of smoking behavior and 
ND during adolescence. Adolescents were recruited in seventh grade, as there is a higher 
probability that they never smoked cigarettes compared to higher grades (never smokers: 
91.0% 7th grade vs. 80.8-52.3% 8-12th grades; Health Canada, 2012). The Institutional 
Review Board of Concordia University approved the AdoQuest study (#1000116). 
Procedure 
After receiving approval from the school boards, school principals and teachers 
were contacted to obtain their authorization to collect data during class time. Informed 
consent forms were sent home to parents with the students. Data collection consisted of 
two visits in each classroom. At the first visit, research personnel provided standardized 
information about the study objectives and confidentiality. Participants were instructed to 
complete a self-report questionnaire silently. While adolescents were completing 
questionnaires, trained research assistants collected a saliva sample (cotinine) and hair 
sample (nicotine) from each student.  At the end of the first visit, passive nicotine 
monitors were distributed for participants to wear on themselves for the next seven 
consecutive days. The second visit occurred one week later when research assistants 
returned to the classrooms to collect the passive nicotine monitors. 
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Measures 
Social Smoking Situations (S3) Scale. Social exposure to smoking was assessed with the 
S3 Scale, which measures contextual situations of smoke exposure to parental, sibling, 
and peer smoking (Racicot et al., 2014). Adolescents rated their current level of smoke 
exposure in each situation (e.g., “my friends smoke after school”; 0 = not true, 1 = 
somewhat true, 2 = very true). Items were averaged to compute a S3 Total score, which 
represents a mean ranging from 0 to 2. Higher S3 scores indicate greater contextual 
exposure to smoking. Similarly, we computed a separate score for each version (parents, 
siblings, peers), and each of the seven subscales derived from principal components 
analysis. This scale has excellent internal consistency reliability (Cronbach’s α = .92-93; 
Racicot et al., 2014). 
 
Salivary Cotinine. Salivary cotinine samples were assayed in duplicate by Salimetrics, 
LLC (State College, PA, USA). Testing was performed using a highly sensitive enzyme 
immunoassay that requires a volume of 20 µl of saliva for each determination and has a 
.15 ng/mL limit of sensitivity with an intra-assay coefficient of variation of 4.1% 
(Salimetrics, 2011). The mean of the two duplicates was used as the salivary cotinine 
value. In adolescents, a cut-off value of 11.4 ng/ml has been used to differentiate smokers 
from nonsmokers (Kandel et al., 2006). 
 
Hair Nicotine. Approximately 10-15 strands of hair were collected from each student's 
scalp, and the centimeter closest to the root was used for analysis. Hair samples were 
assayed for nicotine using reversed-phase high performance liquid chromatography with 
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electrochemical detection (HPLC-ECD) by the Laboratory Services of Capital Coast 
Health Limited (Wellington, New Zealand) with a limit of quantification of .04 ng/mg 
(Mahoney & Al-Delaimy, 2001). Although HPLC-ECD is not used diagnostically to 
classify adolescents according to their smoking status (personal communication with Dr. 
Wael Al-Delaimy, August 14, 2012), hair nicotine provides an excellent dose-response 
measure of exposure to SHS. 
 
Passive Nicotine Monitors. Passive nicotine monitors measure the concentration of 
nicotine in ambient air (Hammond & Leaderer, 1987; Leaderer & Hammond, 1991). 
Specifically, the monitor consists of a windscreen, a filter treated with sodium bisulfate, 
and a 3.7-cm polystyrene cassette. Adolescents were instructed to wear the monitor 
continuously for seven days, except for bathing/showering, physical activity (e.g., 
swimming, martial arts), and sleeping. When not wearing the monitor, they were asked to 
leave it nearby in their proximal environment (e.g., bedside table while sleeping at night; 
desk on school days). Nicotine collected on the sodium bisulfate filters was assayed by 
gas chromatography with nitrogen selective detection at the School of Public Health, 
University of California – Berkeley. Passive nicotine monitors have a limit of detection 
of 0.01µg. Nicotine concentration was calculated by dividing the quantity of nicotine 
found on the sodium bisulfate filters by the estimated total volume of air sampled over 
seven days (Hammond & Leaderer, 1987). 
 
Smoking Expectancies. Participants completed the French-language version (Racicot, 
McGrath, Hine, O’Loughlin, & Guyon, 2008) of the Smoking Expectancy Scale for 
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Adolescents (Hine, Honan, Marks, & Brettschneider, 2007), which measures two 
principal factors: expected costs (e.g., “get lung cancer”) and expected benefits (e.g., 
“feel less stressed”). Using a 10-point scale (0 = completely unlikely to 9 = completely 
likely), participants rated the probability that each cost or benefit would occur if they 
were smokers. An average score was calculated for each factor (0 – 9). This scale has 
excellent internal consistency (Cronbach’s alpha: expected costs = 0.94, expected 
benefits = 0.92, Racicot et al., 2008). 
 
Temptations to Try Smoking. Participants rated the extent to which they were tempted to 
try smoking in 15 situations (e.g., “With friends at a party”, “When I’m embarrassed to 
be a nonsmoker), using a 5-point scale (not at all tempted to extremely tempted). An 
average score was calculated (0 – 4). This scale has excellent internal consistency among 
adolescents (Cronbach’s alpha = 0.94; Hudmon, Prokhorov, Koehly, DiClemente, & 
Gritz, 1997). 
 
Aversion to SHS Exposure. Using a 3-point scale (strongly agree to do not agree at all), 
participants rated the extent to which they dislike SHS exposure (e.g., “I feel bothered 
when someone smokes around me”), prefer smoke-free places (e.g., “I prefer to study in 
smoke-free environments), and support laws banning smoking inside specific public 
places (e.g., restaurant, schools, hospitals; Martinez-Donate et al., 2007). Scores represent 
an average ranging from 0 to 2, where higher scores represent greater aversion to SHS 
exposure. This scale has good internal consistency (Cronbach’s alpha = .83, Martinez-
Donate et al., 2007). 
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Smoking Susceptibility. Smoking susceptibility was measured using two items from the 
pan-Canadian Youth Smoking Survey (Health Canada, 2007; e.g., “Have you ever been 
curious about smoking a cigarette?), and three items from the study by Pierce and 
colleagues (1996; e.g., “If one of your best friends were to offer you a cigarette, would 
you smoke it?) A composite score was created by summing the items (0 – 11) and 
computing the mean, where higher scores represent greater susceptibility to smoking. 
This coding system has been used previously, and smoking susceptibility was associated 
with social exposure to smoking (ß = .27; Racicot et al., 2011a). 
 
ND Symptoms. Participants answered seven items measuring ND symptoms among 
adolescents. Specifically, six items were derived from an “ND/craving indicator” 
(O’Loughlin, DiFranza et al., 2002; e.g., “How often do you have cravings to smoke 
cigarettes?”) and one item was derived from the Nicotine Dependence Scale for 
Adolescents (Nonnemaker et al., 2004; e.g., “I sometimes have strong cravings where it 
feels like I’m in the grip of a force that I cannot control”). Items were summed and 
divided by the number of items to compute average ND scores, which were log-
transformed to correct for positive skewness. ND symptoms have been associated with 
SHS exposure in a car (OR = 1.2), sibling smoking (OR = 1.8), and peer smoking (OR = 
2.2; Bélanger et al., 2008). 
Analytic Plan 
Linear regression was used to test social exposure to smoking (S3 Total score) and 
pharmacological exposure to nicotine (i.e., salivary cotinine, hair nicotine, nicotine badge 
monitors) as predictors of smoking precursors (i.e., expected benefits, expected costs, 
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temptations to try smoking, aversion to SHS, smoking susceptibility, ND symptoms). 
First, each predictor was tested in univariate modeling. Second, S3 score and each of the 
three pharmacological measures were tested in paired multivariable modeling. Third, S3 
score, each of the three pharmacological measures, and their interaction were tested in 
full multivariable modeling. 
RESULTS 
Descriptive Statistics 
 A total of 406 adolescents completed questionnaires and provided biomarkers 
(52.5% female; Mage = 13.0 years, SD = 0.5). Of these, the analytic sample included 338 
adolescents (83.25%) who endorsed the inclusion criterion that they had "never smoked a 
cigarette, not even a few puffs" (53.0% female; Mage = 12.9 years, SD = 0.4). On average, 
participants reported that the benefits of smoking were "very unlikely" to happen to them, 
while the costs of smoking were "somewhat likely" to happen to them (See Table 1). 
Overall, participants reported they were "not at all" tempted to smoke and they endorsed 
high levels of aversion to SHS exposure. The mean score for ND was low; however, a 
subset of never-smoking adolescents endorsed at least one ND symptom (19.8%). This 
percentage endorsing ND symptoms is higher than that reported in another study of never 
smoking youth using identical items (5%; Bélanger et al., 2008), which is likely 
attributable to the younger age of their sample (5th grade). Mean score for smoking 
susceptibility was low (M = .20, SD = .31), although 41.1% of the sample endorsed at 
least one item positively, and thus, would be classified as susceptible to smoking (Pierce 
et al., 1996).  
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 An examination of the S3 scores indicated that a total of 39.6% of adolescents 
endorsed social exposure to smoking. Specifically, 33.7% endorsed social exposure to 
parental smoking, 14.2% to sibling smoking, and 14.5% to peer smoking. Similarly, 
adolescents reported experiencing social exposure during the following contextual 
situations: social activities (34.3%), mood states (25.7%), meals (28.8%), belongingness 
(13.3%), quiet activities (11.2%), unpleasant activities (21.6%), and at school (13.9%). 
With respect to pharmacological exposure, values for the biomarkers were below the cut-
off used to distinguish smokers from nonsmokers, suggesting that adolescents accurately 
reported they were never-smokers. Mean salivary cotinine (M = .48 ng/ml, SD = 1.21) 
was lower than the established cut-off value for categorizing adolescents as smokers 
(11.4 ng/ml; Kandel et al., 2006). Mean hair nicotine value (M = .38 ng/mg, SD = 1.40) 
and mean passive nicotine monitor value (M = .59 µg, SD = 2.05) were also consistent 
with values expected from nonsmokers. Further, mean values for all three measures of 
pharmacological exposure were above the lower limit of sensitivity (salivary cotinine = 
.15 ng/ml, Salimetrics, 2011; hair nicotine = 0.04 ng/mg, Mahoney & Al-Delaimy, 2001; 
nicotine monitor = .01µg, Hammond & Leaderer, 1987), suggesting that adolescents were 
exposed to nicotine from SHS.  
Social and Pharmacological Smoke Exposure to Predict Smoking Precursors 
 Linear regression modeling was used to test social exposure and pharmacological 
exposure as differential predictors of smoking precursors. First, when comparing the 
univariate, paired, and full models, pharmacological exposure best predicted smoking 
expectancies in univariate modeling (i.e., univariate were best fitting models). 
Specifically, higher nicotine exposure from ambient air, measured with the passive 
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nicotine monitor, was significantly associated with greater likelihood of expected benefits 
F(1,337) = 5.64, R2 = .02, p = .018, and lower likelihood of expected costs F(1,337) = 
5.00, R2 = .02, p = .026 (See Table 2). Neither social exposure, nor their interaction was 
significantly associated with smoking expectancies.  
 Second, social exposure best predicted temptations to try smoking, aversion to 
SHS exposure, and smoking susceptibility in univariate modeling. That is, higher S3 total 
score was significantly associated with more temptations to try smoking F(1,337) = 8.10, 
R2 = .02, p = .005, lower aversion to SHS exposure F(1,337) = 11.99, R2 = .04, p = .001, 
and greater smoking susceptibility F(1,337) = 20.73, R2 = .06, p ≤ .001. Neither 
pharmacological exposure, nor their interaction was significantly associated with these 
precursors.  
Finally, the interaction between pharmacological exposure and social exposure 
best predicted ND symptoms. Specifically, the full model including cotinine (ß = -.19, 
t = -2.15, p = .032), S3 Total score (ß = .19, t = 3.19, p = .002), and their interaction 
(ß = .26, t = 2.71, p = .007) was significantly associated with ND symptoms 
F(3,337  = 10.38, R2 = .09, p ≤ .001. Similarly, the full model including the nicotine 
monitor (ß = -.20, t = -1.87, p = .062), S3 Total score (ß = .21, t = 3.44, p = .001), and 
their interaction (ß = .25, t = 2.21, p = .028) was significantly associated with ND 
symptoms F(3,337) = 9.50, R2 = .08, p ≤ .001. Interpretation of the interaction effects 
indicated greater social exposure was significantly associated with greater ND symptoms, 
but only in the presence of greater pharmacological exposure (see Figure 1).  In other 
words, when adolescents were exposed to higher nicotine, greater social exposure was 
associated with endorsing more ND symptoms. 
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Post-hoc Exploratory Analyses 
 Exploratory analyses were also conducted to evaluate the relation between 
smoking precursors and S3 subscales. S3 subscales were derived from principal 
components analysis (Racicot, et al., 2014) and provide information about the source of 
exposure (who: parents, siblings, peers) and the situational context of exposure (when/ 
where: social activities, moods, meals, quiet activities, belongingness, unpleasant 
activities, at school).  Table 2 includes the univariate associations between these S3 
subscales and each of the six smoking precursors. When examining the source of 
exposure, S3 Peer was more strongly associated with temptations to try smoking and 
smoking susceptibility, whereas S3 Sibling was more strongly associated with aversion to 
SHS. When examining the situational contexts of exposure, S3 Social Activity emerged 
as the subscale that was most consistently associated with temptations to try smoking, 
aversion to SHS exposure, and smoking susceptibility. 
DISCUSSION 
 A growing body of research provides convincing evidence that pharmacological 
exposure to nicotine from SHS is a plausible risk factor for smoking initiation during 
adolescence (cf. Okoli, Kelly, & Hahn, 2007). Social exposure to smoking, however, is a 
well-established risk factor for adolescent smoking (USDHHS, 2012). While social 
exposure was not associated with smoking expectancies, it did significantly predict 
greater temptations to smoke, lower aversion to SHS exposure, and greater smoking 
susceptibility, which is consistent with previous research. Conversely, greater 
pharmacological exposure to nicotine from SHS was associated with greater expected 
benefits and lower expected costs. Importantly, this study is the first to document a 
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relation between pharmacological exposure and smoking expectancies. Finally, greater 
social exposure was associated with greater ND symptoms, but only in the context of 
greater pharmacological exposure. Taken together, this study highlights a dose-response 
relation between smoke exposure (social and pharmacological) and the development of 
precursors to smoking among never-smoking adolescents. This will, in turn, confer 
greater risk for smoking initiation.  
Current findings corroborate previously reported research demonstrating a link 
between greater social exposure and greater smoking susceptibility (Azagba & Asbridge, 
2013; Leatherdale, Brown, Cameron, & McDonald, 2005; Schuck, Otten, Engels, & 
Kleinjan, 2012). These results extend earlier findings of an association between greater 
social exposure and greater expected benefits and lower expected costs (Hine et al., 2007; 
Racicot et al., 2011a); greater social exposure and greater ND symptoms (Bélanger et al., 
2008; Racicot et al., 2011a, 2011b, 2013); and greater pharmacological exposure and 
greater ND symptoms (Okoli, Rayens, & Hahn, 2007). Taken together, the present study 
replicated and extended findings from an emerging research area postulating that 
pharmacological exposure to nicotine from SHS is a unique risk factor for smoking. As 
such, current results are consistent with previous studies showing that pharmacological 
exposure to nicotine increases the risk of prospective smoking initiation during 
adolescence (Becklake et al., 2005); predicts withdrawal signs among nicotine-naïve 
strain rats (Small et al., 2010); and leads to nAChRs occupancy in the brains of 
nonsmoking adults (Brody et al., 2011).  
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Pharmacological Exposure to Nicotine as a Unique Risk Factor for Smoking 
 Our results indicate the nicotine monitor, a measure of the total concentration of 
airborne nicotine over seven days, best captured smoking expectancies that include a 
comprehensive list of expected benefits (i.e., affect control, social benefits, boredom 
reduction, weight control) and expected costs (i.e., addiction, appearance costs, social 
costs, health costs) in relation to cigarette smoking (Hine et al., 2007). Unlike salivary 
cotinine and hair nicotine, the monitor may represent the overall intensity of nicotine 
exposure through SHS, and is not affected by bodily functions like metabolism. Contrary 
to expectations, hair nicotine did not emerge as a significant predictor of smoking 
precursors. Studies investigating genetic differences in rates of nicotine metabolism 
suggest that individuals who metabolize nicotine rapidly could have lower biomarker 
values that similarly exposed individuals who metabolism nicotine slowly (Chenoweth, 
O’Loughlin, Sylvestre, Tyndale, 2013; Malaiyandi, Sellers, & Tyndale, 2005). However, 
genetic differences should have affected salivary cotinine values similarly. It is possible 
that extraneous factors (youth dying their hair or applying other chemicals) may explain 
this non-significant result. Future studies are needed to address that question.    
As posited by Anthonisen and Murray (2005), our results support the plausibility 
of a physiological pathway between nicotine exposure from SHS and smoking behavior, 
irrespective of social modeling. Although the nature of such a pathway remains to be 
elucidated, the neuronal effects of nicotine in the brains of never-smokers could 
conceivably resemble those observed in smokers. Benowitz (2010) reported that the 
pathway from the ventral tegmental area to the nucleus accumbens in the mesolimbic 
dopaminergic system has been linked to dependence in smokers; thus, this pathway could 
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be a potential candidate. According to the Sensitization-Homeostasis Model, 
neuroadaptations can be observed soon after administration of low nicotine doses 
(DiFranza, Huang, & King, 2012), which poses the question as to whether nicotine intake 
from SHS exposure could suffice in triggering such neuroadaptations. Given that 
nonsmokers exposed to SHS can absorb concentrations of nicotine related to nicotine 
discrimination in smokers (Pacifici et al., 1995; Perkins et al., 2001), the present study 
lends support to the possibility of neuroadaptations induced by nicotine exposure through 
SHS.  
Okoli, Kelly, and Hahn (2007) raised the hypothesis that repeated nicotine 
absorption from SHS may contribute to greater tolerance of its aversive sensations, which 
could possibly make initial experiences with active smoking less aversive and, 
consequently, more rewarding. Positive responses when smoking one’s first cigarette 
(e.g., relaxation) have been linked to greater ND (Ursprung, Savageau, & DiFranza, 
2011), while experiencing positive experiences during SHS exposure has been associated 
prospectively with greater smoking susceptibility (Lessov-Schlagger, Wahlgren, Liles, 
Jones et al., 2011). In the context of the present findings, one could contend that greater 
pharmacological exposure leads to the development of positive beliefs (e.g., “smoking 
helps calm down”) and unawareness of negative consequences (e.g., “smoking damages 
health”), which could plausibly explain why adolescents continue to smoke following an 
initial pleasant experience. Overall, nicotine intake from SHS is a probable, unique risk 
factor for smoking, regardless of social exposure to smoking. This suggests that exposure 
to nicotine, even in the absence of smokers (i.e., third-hand smoke), could confer risk. 
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Social Exposure to Smoking as a Unique Risk Factor for Smoking 
 Adolescents who spend time with smokers engage in social learning while being 
simultaneously exposed to environmental cues across various contextual situations. 
Current findings showed social exposure best predicted precursors which appear to be 
based on principles of social modeling and conditioning. As an example, greater 
temptations to try smoking in different situations (e.g., feeling tempted to smoke when at 
a party with friends) imply observational learning of peer smoking within a specific 
contextual situation (i.e., a party). Lower aversion to SHS exposure (e.g., being more 
unfavorable to smoking bans in various settings, such as public transit) could be linked to 
witnessing smokers discuss their disapproval of a smoking ban while in that specific 
setting. Greater smoking susceptibility (e.g., greater likelihood of accepting a cigarette 
offer from a friend) could also be linked to elements of social modeling, such as wanting 
to imitate friends’ smoking behavior and thus, being less likely to decline a cigarette 
offer. Given that these precursors appear to be more psychosocial than biological in 
nature, this may explain why pharmacological exposure did not predict these specific 
precursors.  
 The influence of parental, sibling, and peer smoking has been documented 
extensively (Leonardi-Bee et al., 2011; Hoffman, Sussman, Unger, & Valente, 2006). 
Findings from the current study are consistent with the principles of social modeling 
(Bandura, 1977) across varied contextual situations (Van Gucht, Van der Bergh, Beckers, 
& Vansteenwegen, 2010). Most recently, the number of smokers in the social 
environment of never-smoking youth predicted desire to smoke in the presence of 
environmental cues (e.g., sight and smell of smoke; Schuck, Kleinjan, Otten, Engels, & 
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DiFranza, 2013), using the cue-triggered scale of the Autonomy Over Smoking Scale 
(DiFranza, Wellman, Ursprung, & Sabiston, 2009), thereby supporting a theoretical 
connection between social modeling and cue exposure among never-smokers. Overall, 
this study supports previously reported findings, whereby social exposure to smoking, 
even in the absence of direct nicotine exposure (e.g., observing parents smoke outside 
from inside; observing smoking in movies or on television) still constitutes a considerable 
risk factor for smoking. 
Social Exposure in the Presence of Greater Pharmacological Exposure 
 The current study indicated that adolescents with greater social exposure to 
smoking reported more ND symptoms, but only in the presence of greater 
pharmacological exposure, as evidenced by higher values for salivary cotinine and the 
nicotine monitor. In other words, adolescents with greater social exposure did not report 
more ND symptoms when nicotine levels derived from salivary cotinine and the nicotine 
monitor were lower. ND is a multifaceted phenomenon involving biological processes 
(e.g., being physically addicted to cigarettes), social modeling and cue exposure (e.g., 
wanting to smoke when observing peers smoking; wanting to smoke in forbidden places). 
This could plausibly explain why social exposure best predicted ND symptoms only in 
the context of higher pharmacological exposure. Consistent with notions of conditioning, 
a possible mechanism would imply that adolescents inhale nicotine from SHS as they are 
observing smokers describe their ND symptoms in different situations (e.g., being with 
peers who are smoking in the schoolyard while talking about their cravings). Thus, the 
present findings support the idea of three interconnected mechanisms facilitating an 
understanding of the relation between smoke exposure and smoking behavior: social 
	   82 
modeling, conditioning (i.e., exposure to environmental cues), and pharmacological 
exposure to nicotine from SHS (Okoli et al., 2008). Further, this finding provides crude, 
preliminary support to the animal literature reporting complex interactions between 
nicotine and non-pharmacological cues (cf. Chaudhri et al., 2006). Overall, higher social 
exposure paired with higher pharmacological was most predictive of reporting ND 
symptoms. 
Limitations 
 Three methodological limitations require consideration. First, the cross-sectional, 
correlational nature of the study precludes establishment of causal relations between 
nicotine exposure from SHS and smoking precursors. In alignment with animal studies 
(Small et al., 2010; Yamada et al., 2010), experiments could be conducted on humans to 
manipulate pharmacological and social exposure across different conditions (e.g., 
observing smokers in the same room vs. behind a mirror; inhaling nicotine from an 
electronic cigarette vs. inhaling water vapor from an electronic cigarette, etc.) and to 
assess their consequences on temptations to try smoking, ND symptoms, or susceptibility. 
Consistent with previous imaging research (Brody et al., 2011), future neuroimaging 
studies could consider whether nicotine exposure induces neural changes during 
adolescence by comparing the brains of never-smokers frequently exposed to nicotine to 
those of never-smokers with no or minimal exposure. 
Second, we did not examine whether adolescents were compliant with monitor 
instructions. Nevertheless, we relied on three distinct indicators of pharmacological 
exposure for triangulation of nicotine exposure. In addition to utilizing the monitor, 
which provides an estimate of the total concentration of airborne nicotine in youth’s 
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immediate environment (Hammond & Leaderer, 1987), we used a short-term (cotinine, 2-
4 days; Jaakkola & Jaakkola, 1997) and a long-term (hair nicotine, 30-31 days; Al-
Delaimy, 2002) estimate of nicotine exposure. The moderately high amount of overlap 
between the three pharmacological indicators (ravg = .52) strongly suggests that 
adolescents wore the monitor as instructed. Further, we used the S3 Scale to measure 
social exposure to smoking, which focuses on contextual situations of exposure and 
represent an enhanced psychometric instrument compared to traditional measures of 
social exposure (Racicot et al., 2014).  
Third, the present study focused on smoking precursors rather than smoking 
initiation per se. It is recommended that future research test the longitudinal relation 
between pharmacological exposure and key smoking behavior milestones, including 
initiation and daily smoking. However, investigating the risk factors that set never-
smokers at risk of initiating smoking from those not at risk is important. Such results 
among never-smokers could permit researchers to prospectively evaluate the effects of 
smoke exposure on age of onset or the rate of progression through the different smoking 
stages. 
Conclusions 
This study is the first to report that nicotine exposure from SHS poses a risk for 
developing precursors to smoking. The psychoactive effects of nicotine have been 
hypothesized as a plausible mechanism explaining the association of greater exposure to 
nicotine from SHS with greater expected benefits and lower expected costs of smoking. 
Moreover, this study demonstrated that greater social exposure is related to greater ND 
symptoms, but only in the presence of greater pharmacological exposure. This suggests 
	   84 
that social exposure is necessary, but not sufficient in explaining ND symptoms among 
never-smokers. Public health implications include that smoking bans should be 
implemented in homes and cars where youth spend time, given that it is not just watching 
smokers that matters, but also being exposed to nicotine in their absence. From a smoking 
cessation perspective, this study could inform current debates pertaining to the efficacy 
and safety of nicotine delivered via electronic cigarettes.  
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Table 1   
Descriptive Statistics   
Variables M (SD) 
Expected benefits (0 – 9) 2.46 (1.66) 
Expected costs (0 – 9)  5.83 (2.17) 
Temptations to try smoking (0 – 4) .26 (.43) 
Aversion to SHS exposure (0 – 2) 1.75 (.41) 
Nicotine Dependence Symptoms (0 – 3) .08 (.20) 
Smoking Susceptibility (0 – 2) .20 (.31) 
S3 Total Score .07  (.15) 
S3 SCORES (VERSION)   
Parents (0 – 2)  .17 (.35) 
Siblings (0 – 2) .02 (.13) 
Peers (0 – 2) .03 (.16) 
S3 SCORES (SUBSCALES)   
Social Activities (0 – 2) .11 (.21) 
Moods (0 – 2) .07 (.18) 
Meals (0 – 2) .07 (.19) 
Belongingness (0 – 2) .02 (.12) 
Quiet Activities (0 – 2) .01 (.07) 
Unpleasant Activities (0 – 2) .12 (.34) 
At School (0 – 2) .04 (.20) 
Salivary cotinine (ng/ml) .48 (1.21) 
Hair nicotine (ng/mg) .38 (1.40) 
Passive nicotine monitor (µg/m3) .59 (2.05) 
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Table 2 
Univariate Regression Models Predicting Risk Factors for Smoking Initiation 

























β t  β t 
Age 
 
    .06  1.19 
 
-.01     -.12 
 
  -.01    -.17 
 
   -.03    -.55 
 
  -.03  -.56     .08 1.48 
Sex 
 
    .05    .93 
 
 .01      .23 
 
   .00      .02 
 
    .07   1.32 
 
   .06 1.07    -.03  -.57 
Social Exposure                   
  S3 Total Score      .08  1.43  -.02     -.38     .15    2.85**     -.19  -3.46**     .24 4.55**     .26 4.84** 
  Parenta 
 
    .03    .61 
 
-.02     -.27 
 
   .07    1.20 
 
   -.11  -2.00* 
 
   .15 2.75**     .16 2.96** 
  Siblinga 
 
    .06  1.18 
 
 .01      .11 
 
   .06    1.18 
 
   -.26  -4.88** 
 
   .16 2.89**     .16 3.02** 
  Peersa 
 
    .09  1.60 
 
-.03     -.53 
 
   .22    4.21** 
 
   -.04    -.81 
 
   .21 3.94**     .22 2.12** 
  Social Activitiesa      .08  1.44  -.02     -.29     .17    3.12**     -.20  -3.72**     .26 4.98**     .25 4.74** 
  Moodsa      .06  1.17  -.02     -.39     .12    2.13*     -.13  -2.38*     .21 2.01**     .18 3.40** 
  Mealsa      .05    .94  -.02     -.41     .04      .68     -.12  -2.16*     .04   .73     .16 3.03** 
  Belonginga      .08  1.54   .02      .32     .16    3.05**     -.17  -3.12**     .20 3.73**     .19 3.58** 
  Quiet Activitiesa      .07  1.30  -.01     -.16     .11    1.99*     -.22  -4.05**     .17 3 .09**     .22 4.16** 
  Unpleasanta      .05    .87   .01      .14     .06    1.07     -.10  -1.76     .15 2.86*     .17 3.17** 
  Schoola      .08  1.54  -.06   -1.02     .23    4.26**     -.09  -1.58     .23 4.34**     .23 4.24** 
Pharmacological Exposure              
  Cotinine 
 
    .09  1.58 
 
-.04     -.76 
 
  -.04     -.65 
 
   -.07  -1.26 
 
   .01   .24     .09 1.64 
  Hair 
 
    .05    .96 
 
-.06   -1.10 
 
   .00      .08 
 
   -.15  -2.82** 
 
   .10 1.87     .09 1.56 
  Monitor 
 
    .13  2.38* 
 
-.12   -2.24* 
 
   .00      .05 
 
   -.05    -.94 
 
   .02   .37     .10 1.85 
Note. a = S3 subscales; variables investigated in exploratory analyses only. β = standardized beta coefficient.  
          *p ≤ .05; ** p ≤ .01 
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Figure 1: Cotinine was median split to facilitate depiction of the significant 
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Figure 1: Interaction between S3 Scores and cotinine to predict 
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GENERAL DISCUSSION 
 In spite of well-intentioned prevention programs and punchy media campaigns, 
the prevalence of smoking remains too high (e.g., 44% of Québec adolescents in grades 
10-12 try smoking; Health Canada, 2012). Considering that smoking typically begins 
during adolescence and tracks into adulthood (Chassin et al., 2000), identifying and 
understanding the factors that explain why some never-smoking adolescents will 
eventually turn into smokers is still a public health priority. Extant literature has 
convincingly concluded that one of the putative predictors of smoking initiation is 
exposure to others’ smoking. Researchers have become interested in investigating the 
different effects of two major components of smoke exposure on smoking behavior 
during adolescence: 1) social exposure to smoking and 2) pharmacological exposure to 
nicotine from SHS exposure. 
The first major component, social exposure to smoking, has been investigated 
extensively by social scientists. Informed by Social Learning Theory (Bandura, 1977), 
past research has largely conceptualized social exposure to smoking as the influence of 
smoking by role models, such as parents, siblings, or friends (e.g., Collins & Ellickson, 
2004). While social modeling remains a robust mechanistic explanation for the 
underlying association between smoke exposure and smoking initiation, other 
mechanisms have been hypothesized as additional, likely contributors to adolescent 
smoking behavior. In fact, social exposure to smoking implies that adolescents observe 
their parents, siblings, and friends smoke cigarettes (i.e., social modeling), yet few had 
considered that such exposure takes places across a variety of situational contexts that 
could act as environmental cues (e.g., diverse settings, moments, circumstances; Conklin, 
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2006; Van Gucht et al., 2010). Thus, one question that remains is whether contextual 
situations of social exposure to smoking could enable researchers to better measure social 
exposure and, consequently, better predict smoking than existing indicators, which 
typically focus on “who smokes” or “how many individuals smoke” in youth’s social 
environment. 
The second major component, pharmacological exposure to nicotine from SHS 
exposure, has gained more scientific attention recently (cf. Okoli, Kelly, & Hahn, 2007). 
In effect, researchers reported that nonsmokers exposed to high levels of nicotine from 
SHS display biological doses of nicotine as high as those observed in some smokers (Al-
Delaimy et al., 2001; Dimich-Ward et al., 1997). Others indicated that nonsmokers 
exposed to nicotine from SHS absorb quantities of nicotine higher than those required by 
smokers to discriminate the effects of nicotine (Pacifici et al., 1995; Perkins et al., 2001). 
Taken together, such data convincingly demonstrate that nonsmokers exposed to nicotine 
from SHS are not nicotine-naïve, although studies relying on social modeling as their 
paradigm have traditionally overlooked that passive nicotine intake occurs when youth 
observe smokers consume cigarettes. This raises another question as to whether nicotine 
exposure from SHS represents a unique risk factor for smoking onset, regardless of the 
effects of social exposure to smoking. 
The publication of unexpected, intriguing research findings significantly informed 
the development of the present dissertation. Some researchers reported that 
pharmacological exposure to nicotine from SHS predicted smoking initiation during 
adolescence (Becklake et al., 2005), and ND symptoms among nonsmoking adults 
working in bars and restaurants (Okoli, Rayens, & Hahn, 2007). Similarly, children self-
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reporting SHS exposure in a vehicle also endorsed ND symptoms, after adjusting for 
social exposure (Bélanger et al., 2008). Relatedly, the study by O’Loughlin and 
colleagues (2009) showed that endorsing ND symptoms predicted smoking initiation and 
daily smoking. Based on these previously reported findings, we conducted a study in 
which we found that social exposure was linked to smoking expectancies, ND symptoms, 
and smoking susceptibility (Racicot et al., 2011a). Although these findings suggested that 
SHS exposure is a likely contributing factor to smoking precursors, the relative 
contribution of pharmacological and social exposure remained largely unknown. Never-
smokers represent an important population to study, given that pharmacological exposure 
to nicotine from SHS can be measured validly without the confounding effects of active 
smoking. Further, understanding the risk factors present in never-smokers prior to 
smoking uptake could strengthen prevention programming. 
To address these research gaps, the objective of this dissertation was threefold. In 
Study 1, we tested the longitudinal predictors of ND symptoms in a sample of never-
smokers, which is, by definition, inconsistent with current conceptualization of ND 
(APA, 2000). Measures of social exposure were investigated as potential predictors of 
ND symptoms. In Study 2, we developed an enhanced measure of social exposure to 
smoking – the S3 Scale – to more accurately measure the influence of smoking parents, 
siblings, and peers on adolescents. Specifically, we were interested in determining 
whether contextual situations of smoke exposure (i.e., where, when) would better explain 
adolescent smoking than traditional measures which typically focus on the absence or 
presence (e.g., “does your mother smoke: yes/no”), or the number (e.g., “two of my 
closest friends smoke”) of smokers. In Study 3, we evaluated the differential effects of 
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social exposure to smoking and pharmacological exposure to nicotine from SHS on 
smoking precursors to determine whether both exposure routes were significant 
predictors. Altogether, the ultimate goal of this dissertation was to evaluate the two major 
components of smoke exposure (social and pharmacological) as potential mechanisms 
explaining the development of precursors to smoking, which have been involved in the 
transition from never smoking to ever smoking.  
Using longitudinal data from the NDIT study, Study 1 identified peer smoking, 
stress, and alcohol use as significant predictors of ND symptoms. By demonstrating that 
specific predictors could be used to statistically model reports of ND symptom in a 
sample of never-smokers, we provided further evidence that adolescents do not 
mistakenly or randomly endorse ND symptoms. Since the NDIT study did not include 
biomarkers of nicotine exposure, it was impossible to test pharmacological smoke 
exposure as a potential predictor of ND symptoms. Nevertheless, Study 1 was the first to 
demonstrate a longitudinal relation between social exposure and reports of ND symptoms 
by never-smokers, which represents a meaningful contribution to the literature. 
According to our findings, reports of ND symptoms by never-smokers should not be 
considered spurious; instead, they should be viewed as another target for the prevention 
of smoking. However, some researchers have raised criticism, arguing that measurement 
error is the key reason linking social exposure to ND symptoms in nonsmokers. 
In Study 2, we hypothesized that social exposure to smoking, as a theoretical 
construct, encompasses both observing smokers and the contextual situations in which 
the exposure takes place. Accordingly, we developed the S3 Scale to assess the contextual 
situations in which adolescents witness their parents, siblings, and peers smoke. Using 
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cross-sectional data from the AdoQuest Study, we found the S3 Scale more strongly 
predicted smoking behavior and smoking expectancies than existing measures of social 
smoke exposure (e.g., “who is smoking”). We concluded that the S3 Scale represents an 
enhanced psychometric instrument which permits more comprehensive assessment of the 
effects of social exposure to smoking. Researchers could use the S3 Scale as an 
alternative to traditional measures to study temporal relations between contextual 
situations of exposure to smoking and eventual smoking uptake. This holds promise for 
assisting researchers in pinpointing high-risk situations for smoking behavior more 
efficiently. Further, using the S3 Scale represents a judicious methodological decision to 
help researchers distinguish the effects of social exposure from those of pharmacological 
exposure more precisely. 
In Study 3, we investigated the differential relations of social and 
pharmacological exposure to smoking with smoking precursors, using cross-sectional 
data from the AdoQuest study. This study is the first to demonstrate an association of 
greater pharmacological exposure with greater expected benefits and lower expected 
costs. Further, this is the first study to document the finding that greater social exposure 
is associated with more ND symptoms, but only in the context of greater pharmacological 
exposure. Congruent with previous findings, greater social exposure was associated with 
greater temptations to try smoking, greater smoking susceptibility, and lower aversion to 
SHS exposure. Overall, Study 3 enabled us to support the hypothesis that 
pharmacological exposure to nicotine from SHS is a plausible, unique risk factor for 
smoking behavior during adolescence. 
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Taken together, this research program provides additional, stronger evidence that 
exposure to nicotine via SHS is a formidable risk factor for smoking precursors and, 
ultimately, smoking behavior. The distinctive feature of this research program pertains to 
its emphasis on dismantling the major components of smoke exposure (social vs. 
pharmacological), and examining their relative consequences on increasing risk of 
adolescent smoking. Developing the S3 Scale and testing it against three objective 
measures of nicotine exposure from SHS is an original contribution that bridges gaps in 
scientific knowledge. 
Present Findings in Relation to Current State of Knowledge 
 In this dissertation, we highlighted the pertinence of considering contextual 
situations when measuring social exposure to smoking. While the cue-reactivity 
framework largely focuses on cues associated with actual smoking (Carter & Tiffany, 
1999), it has placed less emphasis on environmental cues in the context of social 
exposure to smoking. Thus, this dissertation extends cue-reactivity findings in animals 
(Caggiula et al., 2001) and smokers (Conklin, 2006; Cronk & Piasecki, 2010; Dunbar et 
al., 2010; Shiffman, et al., 2002; Tagmat et al., 2011; Van Gucht et al., 2010). Consistent 
with the position taken by Okoli et al. (2008), we posit that social exposure to smoking 
encompasses elements of both social learning (i.e., observing and imitating role models) 
and cue-reactivity (i.e., observing role models smoke cigarettes across different 
contextual situations). The importance of non-nicotinic factors in explaining smoking 
behavior is a known phenomenon. In fact, nicotine has been shown to enhance the 
reinforcing effects of non-pharmacological cues paired with nicotine use, as well as the 
reinforcing effects of non-nicotine cues that are not paired with nicotine (Caggiulia et al., 
	   94 
2009; Chaudhri, et al., 2006). DiFranza and Wellman (2005) have also proposed a role 
for non-nicotinic cues in their Sensitization-Homeostasis Model. 
Furthermore, conclusions from the present dissertation corroborate and extend 
findings from different frameworks, ranging from physiological studies in animals to 
biopsychosocial studies in humans.  From a neurobiological perspective, current 
conclusions are consistent with animal studies showing that nicotine-naïve rats exposed 
to nicotine exhibit nicotine withdrawal signs (Small et al., 2010; Yamada et al., 2010), 
and with neuroimaging studies in humans showing that nAChRs occupancy in smokers is 
not statistically different from that in nonsmokers in the aftermath of nicotine exposure 
through SHS (Brody et al., 2011). The Sensitization-Homeostasis Model developed by 
DiFranza and Wellman (2005) posits that irregular nicotine self-administration in 
experimental smokers may help to explain the development of sensitization, which has 
been considered a plausible mechanism related to smoking progression (Vezina et al., 
2007). The Sensitization-Homeostasis Model was not developed with respect to SHS 
exposure; nonetheless, it could possibly be extended to nonsmokers who, just like 
experimental smokers, can be irregularly exposed to nicotine via SHS. Further, our 
findings are consistent with a new line of research reporting that experiencing positive 
sensations when exposed to nicotine from SHS (e.g., feeling relaxed) increases the 
likelihood of susceptibility (Lessov-Schlaggar, Wahlgren, Liles, Ji et al., 2011; Lessov-
Schlaggar, Wahlgren, Liles, & Jones, 2011), whereas those who perceive SHS exposure 
as unhealthy are less likely to initiate smoking (Song et al., 2009). 
 
 
	   95 
General Methodological Limitations  
 Two key limitations of this research program merit consideration. First, 
participants completed self-report questionnaires, and no other informants (e.g., first-
degree relatives, friends) provided information. Although home visits could be conducted 
to gather additional data about youth’s exposure to smoking, previous reports have 
established that youth reliably report smoking-related information (Eppel et al., 2006; 
Harakesh, Engels, de Vries et al., 2006). Importantly, participants provided salivary 
cotinine and hair nicotine samples, and wore the passive nicotine monitor for a week, 
which suggests that collecting collateral data would not necessarily improve 
measurement accuracy. 
Second, all three studies used a correlational design and Study 2 and Study 3 
relied exclusively on cross-sectional data, which precludes establishment of temporal and 
causal associations. As an example, this dissertation did not allow for an evaluation of the 
long-term effects of past pharmacological exposure to nicotine, although hair nicotine 
provides an estimate of nicotine exposure over the last 30 days (Mahoney & Al-Delaimy, 
2001). Moreover, this dissertation did not investigate genetics as a contributing factor to 
smoking precursors. While adolescents whose family members smoke are more at risk of 
smoking themselves because of a shared genetic vulnerability (Avenevoli & Merikingas, 
2003), genes moderate the rate of nicotine metabolism (slow vs. fast metabolism) due to 
their effects on the hepatic enzyme CYP2A6 (Malaiyandi et al., 2005). Recent research 
suggests that adolescents who metabolize nicotine slowly smoke more cigarettes and are 
more dependent on nicotine (Rubinstein, et al., 2013), while others have found that slow 
metabolism increases likelihood of smoking cessation among adolescents (Chenoweth et 
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al., 2013). Genetic differences between individuals could affect biomarker values (Avila-
Tang et al., 2013; Jaakkola & Jaakkola, 1997), such that higher pharmacological 
exposure could be attenuated by faster nicotine metabolism when examining biomarker 
values. In fact, greater pharmacological exposure paired with slower nicotine metabolism 
could lead to higher biomarker values than greater pharmacological exposure paired with 
faster metabolism. Prospective studies should test whether nicotine metabolism 
moderates the relation between pharmacological exposure and outcomes for smoking. 
Recommendations for Future Research 
Conclusions from the present dissertation motivated us to think about the next 
questions that other researchers or we should address. First, it is recommended that 
studies use longitudinal data to investigate the unique effects of social and 
pharmacological exposure on smoking initiation, and to evaluate the possibility that the 
association of social exposure with smoking initiation is moderated or mediated by 
pharmacological exposure (e.g., Wang et al., 2011). Moreover, future research should 
explore the complex relations among smoking precursors, using path analysis or 
structural equation modeling. For example, Okoli and colleagues (2009) found that ND 
symptoms predicted smoking susceptibility, while Bélanger et al. (2008) found that 
smoking susceptibility predicted ND symptoms. Ursprung, DiFranza, Costa, and 
DiFranza (2009) reported no relation between ND symptoms and smoking expectancies. 
Unraveling these intricate relations requires further research. Second, studies relying on 
the animal model have the potential to experimentally isolate the effects of nicotine 
exposure from SHS among nonsmokers. Recently, Cohen and George (2013) developed 
an animal model in which rodents are exposed to nicotine vapors in a non-contingent 
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fashion, which simulates the reality that nonsmoking humans are intermittently exposed 
to nicotine from SHS. Further, they contend that this line of work could plausibly help 
determine whether electronic cigarettes represent an effective cessation technique, 
although the safety of electronic cigarettes, which only deliver doses of nicotine, has not 
been established yet (Chen, 2012; Odum, O’Dell, & Schepers, 2012). 
Public Health Implications 
 Over the last few years, public health organizations have deployed considerable 
effort to reduce youth’s exposure to SHS. Smokefree policies in homes, cars, school 
settings, and multi-unit housing have been recommended (e.g., Leatherdale & Ahmed, 
2009; Lee et al., 2012; Pizacani, Maher, Rohde, Drach, & Stark, 2012). Exposure to high 
concentrations of nicotine from SHS in automobiles, for example, is very preoccupying 
from a public health perspective (Jones, Navas-Acien, Yuan, & Breysse, 2009). Based on 
the present dissertation, we strongly support the necessity of implementing and enforcing 
smokefree laws to protect youth from SHS exposure. In addition to recommending that 
smokers abstain from smoking in the presence of youth, we suggest that smokers abstain 
from smoking in places where youth spend time, even in their absence. As an example, 
parents should avoid smoking inside the family car, even when they are alone, given that 
their children will be exposed eventually to nicotine from the residual smoke (thirdhand 
smoke). Moreover, we suggest that researchers further investigate emissions of nicotine 
from electronic cigarettes. Given that they deliver doses of nicotine, the question remains 
as to whether or not electronic cigarettes represent a dangerous source of nicotine 
exposure. 
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Conclusions 
 Altogether, these dissertation findings generate new knowledge about the 
differential effects of social and pharmacological exposure on smoking risk during 
adolescence. Evidence supports the possibility of a physiological pathway between 
nicotine exposure from SHS and eventual smoking, irrespective of the effects of social 
exposure to smoking. However, future research is required to confirm and identify the 
nature of such a pathway. From a health prevention viewpoint, our findings could be used 
to further inform public health policy-making, thereby encouraging complete smoking 
bans in environments where youth spend time, including households, cars, multi-unit 
housing, and school premises. 
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